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Abbreviations 
 
DRD  Drug related death 
 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
 
GMR  General Mortality Register  
 
ICD International Statistical Classification of Diseases and Related Health 
Problems  
 
SR  Special Register 
 
WHO  World Health Organisation  
 
Main ICD-10 codes used in this report: 
 
F10-F19: Mental and behavioural disorders due to psychoactive substance use; 
I46.9: Cardiac arrest, unspecified; 
R96: Other sudden death, cause unknown; 
R98: Unattended death; 
R99: Other ill-defined and unspecified causes of mortality; 
T40: Poisoning by narcotics and psychodysleptics;  
T43.6: Poisoning with Psychostimulants with abuse potential 
T50.9: Other and unspecified drugs, medicaments and biological substances; 
X41/X61/Y11: Accidental/Intentional/Undetermined intent, self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified; 
X42/X62/Y12: Accidental/Intentional/ Undetermined intent, poisoning by and 
exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified; 
X44/X64/Y14: Accidental/Intentional/Undetermined intent, poisoning by and 
exposure to other and unspecified drugs, medicaments and biological substances; 
X49/X69/Y19: Accidental/Intentional/ Undetermined intent,poisoning by and 
exposure to other and unspecified chemicals and noxious substances; 
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Executive summary 
 
• Discrepancies observed in drug related deaths are not solely due to differences in 
the actual deaths due to drugs but also due to certification and coding 
differences. 
 
• The main aim of this part of the project was that through the collection of 
detailed data on drug related deaths from a number of countries, to further 
analyse their data in terms of codification practices and the changes in the codes 
and numbers of reported cases of drug related deaths, before and following the 
WHO updates in 2002/2003. 
 
• The following 9 out of 10 countries contributed data at different levels of detail: 
Bulgaria, Denmark, England, France, Germany, Italy, Norway, Poland and Spain; 
Country experts were also involved in the compilation of their country report.  
 
• Depending of the data sent the following analysis was carried out:  
 
o Description of the full disaggregated dataset of DRD cases including all 
retrieval codes and information. 
o Description of what cases are being captured under the ICD codes of X44, 
X64 and Y14. 
 
• Of the nine countries which have sent us data only Denmark, Norway and 
recently the United Kingdom have fully implemented ICD-10 updates. 
 
• In some countries the ICD-10 updates had no impact on trends in drug related 
deaths reported according to selection B. This was either due to updates not 
being implemented or in countries which have fully implemented ICD-10 updates  
this also had no impact on the overall trend in drug related deaths. In these 
countries a shift in coding e.g. from F to X or from X42 to X44 might have 
occurred however the corresponding new code was also included in the new 
selection B. 
 
• In a few countries which have partially implemented ICD-10 updates this resulted 
in a shift in coding with a corresponding decrease in the number of drug related 
deaths reported according to selection B. 
 
• The use of X44/X64/Y14 varies between countries and often depends on whether 
or not T codes are used in the coding of drug related deaths. However also in 
those countries which include X44/X64/Y14 in reporting DRDs according to the 
EMCDDA protocol still have a number of deaths being reported under these 
codes which are not reported to the EMCDDA due to the un-specificity of the 
associated T code. 
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• Cases placed under code T50.9  may be those in which not enough information is 
available to be able to identify and therefore code the drug specifically or the 
type of drug was specified, but is classified among the "rest" category in T50.9 as 
no specific ICD 10 code exist. The extent of use of T50.9 varied between 
countries as was the extent of use of other unspecified drug related death codes 
such as X49/X69/Y19. 
 
• A number of recommendations detailed at the end of the document are outlined 
in this summary: 
 
• Countries are encouraged to report according to both sources (selection B 
and selection D) as this is useful especially in monitoring trends; Linkage 
between the two sources would also be beneficial when feasibly possible. 
• Countries need to make an effort to code all drugs using T codes even if in a 
number of cases not all drugs may be specified.  
• Detailed analysis of the main drugs and trends in drug type should be made 
by countries even if this is not possible at national level. 
• Updates should be implemented according to WHO recommended 
timeframes. Countries should be informed about an update related to drug 
related deaths well in advance. This could be done through WHO invited 
experts at the EMCDDA annual meeting on drug related deaths. 
• Countries are encouraged to carry out bridge coding exercises. 
• In countries where this is possible analysis of cases coded under T50.9 should 
be undertaken. 
• Further discussion by EMCDDA with WHO regarding deaths due to drugs with 
no specific T code should also be considered. 
• Countries should make an effort to obtain more information about drug 
related cases with an unspecified T code e.g. using T50.9   and linkage with 
other registers e.g. a drug register should be considered if permitted.  
• EMCDDA to consider asking for an update of drug related death data 2-3 
years after the initial request to countries to take into consideration possible 
updates. 
• Countries who are aware of gross underestimation in the reporting of drug 
related deaths according to the EMCDDA definition could possibly develop a 
method of estimation to be able to produce a more realistic figure. 
• In countries which code all drugs involved in the death, multiple cause 
analysis can be undertaken to evaluate in more detail the trends in the drugs 
involved in drug related deaths. 
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1. Introduction  
 
The collection of data regarding drug related deaths varies from country to country, 
with variations occurring at certification level and also at codification level. Previous 
work carried out by the EMCDDA (European Monitoring Centre for Drugs and Drug 
Addiction) and presented at the 2015 September 21-22 annual expert meeting1 has 
shown that coding of drug related deaths varies between countries, and the 
adoption of the ICD-updates in DRDs of 2002/03 (to be implemented in 2006 and as 
described in the EMCDDA DRD protocol2) has not been uniform across countries1. 
The first report looked at codification issues in all countries who send data to the 
EMCDDA through analysing data from the EMCDDA website. The second report 
looked at the information flow to the general mortality register based on replies 
given by countries to the EMCDDA questionnaire developed in 2009 which was 
repeated in 2016. Through these two reports one could understand that 
discrepancies exist between countries as to the extent and accuracy of the collection 
of data on drug related deaths and subsequent reporting to the EMCDDA. The 
discrepancies observed in drug related deaths described in the graph below are not 
solely due to differences in the actual deaths due to drugs but also due to 
certification and coding differences.  
  
 
 
 
Figure 1: Drug induced mortality rate 15-64 years per 100,000 
Source: EMCDDA website, country overview3 
 
Differences between countries start at the certification process with autopsy rates 
varying widely between countries, Also the extent of the autopsy and type of 
toxicological investigations carried out may vary. Overall autopsy rates in most countries 
are showing a downward trend (figure 2). 
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Table 1: Autopsy Rate in different European Countries: Percentage for all deaths  
(source: WHO: HFA DB)4 
     
 
Therefore the extent of investigation contributes to the accuracy of death 
certification in drug related deaths and is just one step in the whole process were 
variations between countries exist. The accurate coding of drug related deaths 
including the implementation of ICD-10 updates in large part depends on the 
information put down on the death certificate. As seen in the first report 
implementation of ICD-10 updates varies between countries for a number of reasons 
and this report will focus on more in depth analysis of codification practices of drug 
related death and the impact of the ICD-10 updates. 
 
2. Aims and objectives 
 
2.1 Main Aim 
 
The main aim of this project is, that through the collection of detailed data on drug 
related deaths from a number of countries, to further analyse this data in terms of 
codification practices and the changes in the codes of the reported cases, in the 
different countries before and following the WHO updates in 2002/2003. 
Countries First available Last available
004 Austria 34.7 - 1984 12.7 - 2014
009 Bulgaria 19.9 - 1980 4 - 2014
010 Croatia 10.95 - 1994 6.4 - 2014
011 Cyprus 9.21 - 1992 8.94 - 2014
012 Czech Republic 33.5 - 1970 17.9 - 2014
013 Denmark 52.1 - 1985 3.9 - 2012
014 Estonia 33.5 - 1989 19.2 - 2014
015 Finland 32.6 - 1970 22.7 - 2014
020 Hungary 51 - 1990 37.67 - 2014
022 Ireland 15.01 - 1994 17.88 - 2002
027 Latvia 36.4 - 1980 15.3 - 2014
028 Lithuania 34.6 - 1988 16.9 - 2014
029 Luxembourg 0.9 - 1998 1.9 - 2014
030 Malta 7.59 - 1999 8.31 - 2014
033 Netherlands 12 - 1981 3.9 - 2008
034 Norway 10.6 - 1992 7.9 - 2014
036 Portugal 7.7 - 1980 6.3 - 2005
038 Romania 13.8 - 1988 4.9 - 2014
042 Slovakia 25.1 - 1980 12.72 - 2013
045 Sweden 41.36 - 1980 11 - 2014
049 Turkey 3.1 - 2009 3.6 - 2013
052 United Kingdom 27.02 - 1980 23.16 - 1989
055 EU 23.53 - 1989 15.41 - 2014
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2.2 Objectives 
 
  
a) Describe the disaggregated dataset of DRD cases (according to what countries 
can provide) including all retrieval codes and information on causes of death. 
b)  Analyse the DRD data from selected countries in order to describe in particular 
the cases captured under X44, X64 and Y14; 
c) Analysis of non-specific codes for each country being studied. 
 
 
The country specific analysis will contribute to a larger overall analysis of all 
countries studied and which will report on common and other particular issues 
identified, comparability issues raised, as well as recommendations and ways 
forward.  
 
 
3.  Methodology 
    
A letter (annex A) was sent to ten countries (Bulgaria, Denmark, England, France, 
Germany, Italy, Norway, Poland, Romania and Spain) chosen as being representative 
of the European Union, asking them to provide information on a list of variables for 
cases with the following ICD-10 codes as underlying cause of death: F11 (.0-.9) to F19 
(.0-.9), (excluding F17), X41, X42, X44, X49, X61, X62, X64, X69, Y11, Y12, Y14, Y19, 
R96.0, R96.1, R98, R99 if possible for the last 3 most recent years, from the GMR 
(and also from the SR, should codes be available from these as well).  
The provision of case based data (without identifiers) would allow the most detailed 
analysis possible, however as for some countries it was not possible to provide case 
based data, another letter was sent out to these countries asking for aggregate level 
data for a number of ICD 10 codes (annex B).  
 
Depending of the data sent the following analysis was carried out: 
 
Description of what cases are being captured under the ICD codes of X44, X64 and 
Y14. In order to carry out this analysis the relevant T codes used in combination with 
X44, X64 and Y14 would ideally be supplied by the countries to be able to analyse in 
detail what these codes are being used for.  
 
 
Description of the full disaggregated dataset of DRD cases including all retrieval 
codes and information, for the ‘detailed dataset’. This was done for those countries 
which were able to supply the dataset and if possible textual causes of death. A 
detailed analysis was done of the different codes, where DRDs may be present but 
not routinely sent to EMCDDA due to lack of detailed information about the case and 
what % they would contribute too. 
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Each country report produced was discussed with the country national expert prior 
to compiling the report. 
 
 
4. Main Findings 
 
The detailed findings for each country can be accessed through the individual 
country reports (section 5).     
Data was received from nine countries at different level of detail as described in 
table one below. 
 
Country Data sent 
Bulgaria Data according to ST 5: 2012-2014   
Denmark Case based data: 2012-2014 
France Cased based data including text: 2012-2013 
Germany Aggregate level including T codes: 2014 
Italy Aggregate level including T codes: 2011-2013 
Norway Case based data: 2011-2013 
Poland Data according to national definition (no T codes): 2014 
Romania No data 
Spain Aggregate level data: 2012-2014 
United Kingdom 
Wales 
Aggregate level data for England and Wales including T 
codes:2011-2013 
 
Table 2: Description of data sent by the countries 
 
The level of analysis that could be performed depended on the data that was 
provided by the country. However in order to supplement this, the World Health 
Organisation mortality database5 was used to extract aggregate level data over 
various periods of time and according to different ICD-10 codes to analyse drug 
related deaths further.  
 
4.1 The use of X44/X64/Y14 to report drug related deaths according to selection B 
 
As documented in previous work (Part I) not all countries have implemented ICD-10 
updates or have only implemented them partially. Of the nine countries which have 
sent us data only Denmark, Norway and recently the United Kingdom have fully 
implemented ICD-10 updates. Other countries have only partially implemented them 
due to the complete absence or general lack of T codes.  
 
Also most of the countries reviewed send data to the EMCDDA according to selection 
B or selection D. However for Poland data is sent according to their national 
definition only and in Spain data is sent according to its national definition, selection 
B and selection D.  
 
The use of X44/X64/Y14 varies between countries as seen in table 3 below: 
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Country Deaths included under X44/X64/Y14 
Bulgaria No ICD updates so X44/X64/Y14 not used for 
selection B. 
Denmark Deaths included under X44/X64/Y14 include: 
1. Drugs from more than one 
family, but the codes are not 
always drugs as such.  
2. Unintentional wrong-use of 
other or unspecified drug or 
biological substance.  
France X44/X64/Y14 are not reported to the 
EMCDDA due to frequent absence of T 
codes. X44/X64/Y14 are mainly use to code 
‘Accidental poisoning by and exposure to 
other and unspecified drugs, medicaments 
and biological substances’. 
Germany Though the ICD updates and priority list 
related to DRDs has been introduced there is 
no evaluation how regularly it has been 
applied. 
Italy No information 
Norway X44 ("Accidental poisoning by and exposure 
to other and unspecified drugs, 
medicaments and biological substances") is 
used in accidental poisonings either:  
1) by other specified substances, not 
covered in the other groups (X40-X43),  
2) by a combination of substances, where no 
substance is clearly stated as the main 
intoxicant; or 
 3) Were the particular type of substance is 
unknown (but supposed to be a 
drug/medicament. 
Poland X44/X64/Y14 used in national definition but 
not in combination with T codes.  
Spain X44 is frequently used to code deaths due to 
‘overdose’ which is often reported as such 
on the death certificates without any 
additional details. It is included in the 
national definition. 
United Kingdom As per ICD-10 protocol and updates. 
    
Table 3: Use of X44/X64/Y14 by country 
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4.2 General Trends in reporting of drug related deaths according to selection B 
before and after the ICD-10 updates 
 
 In some countries the ICD-10 updates had no impact on trends in drug related 
deaths reported according to selection B. This was either due to updates not being 
implemented e.g. in Bulgaria, or where X44/X64/Y14 is only used sparingly e.g. in 
Germany. Also on the other hand in countries which have fully implemented ICD-10 
updates e.g. in Norway and Denmark this also had no impact on the overall trend in 
drug related deaths. In these countries a shift in coding e.g. from F to X or from X42 
to X44 might have occurred however the corresponding new code was also included 
in the new selection B. 
 
 
 
Figure 2: Trends in the number of drug related deaths according to ICD codes reported in 
selection B in Norway (Source: EMCDDA statistical bulletin) 
 
 
In a few countries which have partially implemented ICD-10 updates this resulted in 
a shift in coding with a corresponding decrease in the number of drug related deaths 
reported according to selection B e.g. Spain. As seen in figure three below the 
number of drug related deaths according to the national definition which includes all 
codes reported in selection B but also includes X44 code is showing a steady 
decreasing trend. On the other hand drug related deaths reported according to 
selection B which includes ICD codes F11, F12, F14-F16, X42, X62 and Y12 but not 
X41/ X61/Y11 as well as X44/X64/Y14 since they do not include T codes has seen a 
drastic drop in the number of drug related deaths around the time of 
implementation of the ICD 10 updates. The fall in the number of drug related death 
around 2006 is associated with a corresponding increase in deaths due to X44 code 
(Figure 4).  
 
The National definition Selection D reports according to the EMCDDA protocol for 
selection D but does not have national coverage. 
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Figure 2: Trends in DRDS in persons aged 15-64 years according to different 
definitions in Spain6 
 
 
 
Figure 3: Trends in DRDs in 15-64 year olds according to the main ICD-10 codes and 
selection B in Spain5 
 
 
4.3 Use of X44/X64/Y14 code in the various countries 
 
As described above the use of X44/X64/Y14 varies between countries and often 
depends as to whether or not T codes are used in the coding of drug related deaths. 
However also in those countries which include X44/X64/Y14 in reporting DRDs 
according to the EMCDDA protocol still have a number of deaths being reported 
under these codes which are not reported to the EMCDDA due to the un-specificity 
of the associated T code. Figure 4 below shows this example in Italy were quite a 
high percentage of deaths are reported as X44/X64/Y14 in combination with T50.9.   
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*Those not according to EMCDDA definition are in combination with T50.9 only 
   
Table 4: Number of drug related deaths according to a selection of ICD codes in Italy 
 
An analysis of the use of X44/X64/Y14 codes in Norway was also carried out and it 
resulted that less than half of X44/X64/Y14 cases fall within the criteria for reporting 
according to selection B (Table 5). 
 
 
 
Table 5: Number and percentage of X44/X64/Y14 cases included in cases reported in 
selection B in Norway 
 
Of the cases which did not fit the selection B criteria, over half the cases were coded 
as X44/X64/Y14 and T50.9 which represents ‘other unspecified drugs, medicaments 
and biological substances’ even though some of them have undergone an autopsy.  
 
In France, which do not report X44/X64/Y14 in selection B, according to the analysis 
undertaken by the French National Focal Point when reviewing all cases of 
X41/X61/Y11 as well as X44/X64/Y14 an additional 76 cases could be considered as 
DRDs according to selection B in 2012. These were not normally included as since 
France do not include T codes, reporting of all X41/X61/Y11 and X44/X64/Y14 should 
not be included as this would represent an overestimation. 
 
 
 
Table 6: DRDs according to ICD 10 codes that would fit selection B and other codes in 
France 
 
In Germany many deaths coded with X44/X64/Y14 are in combination with T50.9 
and therefore drug related deaths which would fit the selection B criteria may be 
among these cases.      
 
CODE EMCDDA NOT EMCDDA
F 397 1
X41,X61,Y11 22 84
X42,X62,Y12 345 0
X44,X64,Y14* 3 224
X49,X69,Y19* 0 8
2011-2013
Year X44/X64/Y14 included X44/X64/Y14 not included Total
2012 40 (37.7%) 66 (62.3%) 106
2013 34 (43.0%) 45 (57.0%) 79
2014 46 (47.4%) 51 (52.6%) 97
Codes According to selection B To include To exclude Total
F 140 0 26 114
X41/X61/Y11 0 11 0 11
X42/X62/Y12 124 0 25 99
X44/X64/Y14 0 65 0 65
Other codes 0 48 0 48
Total 264 124 51 337
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*In combination with specific T codes as specified in annex 2 
 
Table 7: number of DRDs according to selection B or not in persons aged 15=64 years 
in 2014 
 
In Denmark the use of X44/X64/Y14 codes follows the WHO ICD-10 updates and is 
reported to the EMCDDA as per Selection B protocol. Over half (61%) of 
X44/X64/Y14 cases fall within the criteria for reporting according to selection B 
(table 8). These may include cases of T codes combined with F10-F19. 
 
 
 
Table 8: deaths with or without autopsy due to X44/X64/Y14 in 2012/2013 in 
selection B and not in selection B 
 
Cases coded under X44/X64/Y14 in Denmark but which do not fall under selection B 
include cases with specific T codes and others with T50 as per table 3 below. 45 
cases or 35% are coded as T50.9 and most of these (62%) have not undergone an 
autopsy. As seen in other country reports cases placed under this code may be those 
in which not enough information is available to be able to identify and therefore 
code the drug specifically or the type of drug was specified, but is classified among 
the "rest" category in T50.9 as no specific code exist. 
  
 
   
 
Table 9: deaths coded as X44/X64/Y14 in 2012/2013 not in selection B 
 
In England and Wales the use of X44/X64/Y14 is mainly in combination with T50.9 
(Table 10) and often refers to poly-drug cases. An analysis undertaken by the UK 
focal point showed that a high percentage of the cases fit the criteria for reporting to 
the EMCDDA according to selection B (Table 11). 
 
code Included in selection B Not included in selection B
F codes 769 9
X41/X61/Y11* 9 104
X42/X62/Y12* 319 7
X44/X64/Y14* 21 479
X49/X69/Y19* 0 7
2012/2013
autopsy no autopsy autopsy no autopsy
X44/X64/Y14 165 31 57 70
Selection B Not selection B
X44/X64/Y14 not selection B Number in 2012/13
Specific T code 60
T 50 61
Other 6
Total 127
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Table 10: Deaths due to X44/X64/Y14 in combination with T50.9 
 
 
 
Table 11: Percentage of deaths due to X44/X64/Y14 in combination with T50.9 which 
fit the EMCDDA criteria for selection B 
 
This resulted in an updating of drug related deaths according to selection B reported 
by the Focal Point. 
 
4.4 Unspecified deaths codes used to code causes of death in various countries 
 
An analysis of the percentage of deaths within the unspecified general codes I469, 
R96, R98 and R99 was done for the countries participating in this part of the project. 
Data was obtained from the World Health Organisation website and the most recent 
year available was taken for each country and analysed. The percentage of deaths 
per code described above in the younger age groups (15-64) was calculated out of all 
deaths in that particular age group in order to check if unspecified deaths were 
frequent among the age group commonly associated with drug related deaths. 
However no conclusions can be drawn from this analysis as in some countries which 
had low percentages of these unspecified codes had higher percentages of 
unspecified drug related codes and even if the general unspecified codes were high 
this could not directly infer that these were drug related deaths. Table below shows 
an example for all countries for R99: 
 
 
 
Table 12: Percentage of deaths due to ‘R99’ code in various countries in the younger 
age groups5 
 
 
 
 
ICD-10 code plus T code 2011 2012 2013
X44 T50.9 487 471 406
X64 T50.9 157 125 108
Y14 T50.9 97 113 77
Selection B plus T code 2011 2012 2013
X44 T50.9 62.4% (n= 304) 56.2% (n=262) 41.6% (n=169)
X64 T50.9 43.9 % (n=69) 36.8% (n=46) 24.1% (n=26)
Y14 T50.9 37.1% (n=36) 43.4% (n=49) 31.2% (n=24)
Country 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
Bulgaria 4.65 6.69 8.61 5.63 5.39 4.71 3.26 2.36 1.62 1.04
Denmark 3.08 3.67 7.27 6.16 7.00 4.65 3.88 4.35 3.80 4.62
France 8.16 10.41 11.62 10.76 9.89 7.73 6.69 5.09 4.60 3.83
Germany 2.84 4.68 4.46 4.82 5.11 4.52 4.32 3.78 3.34 2.72
Italy 4.34 5.67 4.53 5.18 3.93 3.14 1.71 1.11 0.82 0.49
Norway 1.45 0.74 6.10 2.11 4.05 1.74 3.66 1.65 2.16 1.92
Poland 2.33 2.34 2.72 4.26 4.67 3.87 3.63 3.35 2.83 2.35
Spain 2.62 2.31 1.41 2.74 3.64 2.56 2.45 1.93 1.40 1.33
United Kingdom 1.39 1.47 1.70 1.51 1.81 1.40 1.18 0.76 0.66 0.46
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5. Country Reports 
 
The following sections will go into more detail the topics discussed above through 
the various country reports. From the analysis of the data a number of 
recommendations and conclusions will be presented at the end of the report. 
 
  
5.1 Bulgaria 
    
Situation Analysis regarding ICD-10 coding of DRDs in Bulgaria 
 
In collaboration with the Bulgarian National Focal Point: Georgi Shopov and Momchil 
Vassilev 
 
Background 
 
Bulgaria report drug related deaths according to both the general mortality register 
(GMR) as well as the special register (SR). Autopsy is not obligatory in Bulgaria. 
 
The main source of information for the GMR is the death certificate and drug related 
deaths are reported according to ICD-10 codes: F, X41, X42, X61, X62, Y11, Y12 in 
combination with the T-codes. Bulgaria uses ICD10 first version with no updates. 
 
Information for the SR are obtained from two sources:  The Forensic Medicine and 
Deontology Centers (FMDC) in Sofia (Aleksandrovska Hospital) and the Ministry of 
Interior. The national focal point of Bulgaria in recent years performed a study 
through the Centre of Forensic Medicine and deontology (Alexander's Hospital) in 
Sofia. This was done through a grant agreement with the European Monitoring 
Centre for Drugs and Drug Addiction. Data about drug related deaths was obtained 
in some detail. However this only covers cases of persons who have died in Sofia-city 
and region, and now NFC are unable to retrieve such data for other regional cities in 
Bulgaria. 
 
Estimation of the number of Drug related deaths 
 
When comparing the two sources of data the SR reported total deaths in 2013 and 
2014 combined as 77 deaths, while for the same period the GMR reported 36 
deaths. Also the SR only covers deaths from the region of Sofia City and Sofia region, 
while the GMR reports deaths for the whole country. 
 
Use of X44 and other ICD-10 codes in reporting drug related deaths 
 
2013 was the first year of implementation of the EMCDDA definition (excluding 
X44/X64/Y14) coupled with Т-codes and use of the 4-digits in accordance with ICD-
10 on causes of death. Bulgaria has seen a reduction in the number of drug related 
deaths from 2012 to 2013 and 2014, however it is not clear as to the actual reason 
for this.   
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Analysis of DRDs in Bulgaria 
 
General Trends 
 
As described above the number of DRDs according to selection B in recent years is 
less than that reported according to selection D. Also selection D only covers deaths 
from the region of Sofia City and Sofia region. Deaths according to selection B have 
remained relatively stable except for a spike in 2008.   
 
  
 
Figure 4: Trends in DRDS according to selection B and selection D6 
 
Trends by ICD-10 codes 
 
Bulgaria started using ICD-10 for the year 2005. Using the WHO Mortality database5 
trend analysis of ICD-codes related to drug related deaths was performed. Figure 5 
and 6 below compares trends in DRDs according to ICD codes used in selection B as 
well as X44, X64 and Y14. The main ICD code responsible for DRDs was X42 which did 
not show any changes in trend in the year 2006 when the ICD updates related to 
DRDs should have been implemented. Similarly no change in trend was observed in 
the number of deaths in the other ICD codes including X44 in 2006. This corresponds 
to the fact that ICD-10 updates were not implemented in Bulgaria. 
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Figure 5: Trends in DRDs according to selection B and X445 
 
 
 
Figure 6: Trends in DRDS according to ICD groups5 
 
Unspecified ICD-10 codes  
 
Analysis of unspecified ICD codes as a percentage of total deaths in the age groups 
15-64 revealed a high percentage in the R99 code especially in the younger age 
groups. 
 
 
Table 13: Percentage of deaths according to non specific ICD codes out of total 
deaths in the age group 15-64 during 20125  
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
X44 0.00 0.00 0.30 0.00 0.00 0.00 0.05 0.00 0.00 0.00
X49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
X64 0.00 0.35 0.00 0.00 0.12 0.23 0.00 0.05 0.00 0.02
X69 0.58 0.00 0.30 0.20 0.00 0.08 0.10 0.05 0.02 0.01
Y14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Y19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
R96 0.00 0.35 0.89 0.40 0.24 0.39 0.35 0.19 0.31 0.29
R98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.05 0.02
R99 4.65 6.69 8.61 5.63 5.39 4.71 3.26 2.36 1.62 1.04
I46 0.00 1.06 1.19 2.01 1.92 1.31 1.98 1.47 1.58 1.50
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Discussion and conclusion 
 
The drug-induced mortality rate among adults (aged 15–64) was 3.1 deaths per 
million in Bulgaria in 2014, well below the European average of 19.2 deaths per 
million. Since 2013 Bulgaria has implemented selection B whereby reported cases 
are according to X and Y in combination with T codes, as well as F codes. However no 
ICD updates have been implemented. Bulgaria has seen a reduction in the number of 
drug related deaths from 2012 to 2013 and 2014 and one possible cause could be 
that previously all cases under X41/X61/Y11 were reported while now only those 
specific to EMCDDA definition for selection B are reported. 
 
Drug related deaths according to selection B are underestimated even when just 
comparing to selection D. The increase in DRD deaths according to selection B in 
2008 is not well understood. 
 
The analysis above shows that the percentage of deaths in unspecified codes is quite 
large especially ‘R99’ code and this is a problem related to certification and lack of 
information to complete the death certificate accurately. Estimations of number of 
DRDs may be required to obtain a more accurate picture on drug related deaths in 
Bulgaria. It is also encouraged that updates which include X44/X64/Y14 with the 
relevant T codes should also be implemented. 
 
5.2 Denmark 
 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Denmark 
In collaboration with the Danish National Focal Point: Henrik Sælan & 
Claudia Ranneries 
 
Background 
 
In Denmark there are two sources of information for drug-induced deaths statistics 
namely the Police Register which is the Special Register (SR) and the General 
Mortality Register (Cause of death register) which is administered by the Danish 
Health Data Authority. Data is transmitted to the EMCDDA from both sources; 
however the General Mortality Register (GMR) is the primary source.    
 
There are three forensic medicine institutes in Denmark which do all the post-
mortems (autopsies and toxicological analysis) of suspicious deaths of the country. 
Also since the late 1960’s all unnatural deaths of persons who were former or actual 
drug abusers or any drug abuse/intoxication were illicit drugs is suspected undergo a 
post-mortem. Post-mortem reports are sent to the police. Post mortem information 
is also sent to the General Mortality Registry for possible more precise cause of 
death diagnosis.  Also on an annual basis the Danish Health Authority has a meeting 
with the forensic institutes where borderline cases are discussed.   
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Estimation of the number of drug related deaths 
 
Based on the available information from death certificates and autopsy reports 
(where applicable), the GMR codes the deaths using ICD-10 together with all the 
updates. 
The electronic death certificate has been implemented since 2007.  
 
Use of X44 and other ICD-10 codes in reporting drug related deaths 
 
The General Mortality Register reports according to selection B and has 
implemented all ICD-10 updates related to drug related deaths. 
Deaths included under X44/X64/Y14 include: 
1. Drugs from more than one family, but the codes are not always drugs as 
such.  
2. Unintentional wrong-use of other or unspecified drug or biological 
substance.  
 
Analysis of DRDs in Denmark  
 
General Trends 
 
Both the main source of reporting i.e. selection B and the other source of reporting, 
selection D, show a similar trend in deaths due to drugs, with the main source 
reporting more deaths every year (figure 7). As seen in table 14 below Denmark has 
fully implemented the ICD-10 updates with most deaths reported to the EMCDDA 
according to selection B being either X42/X62/Y12 or X44/X64/Y14. In 2012/2013, 
75% of all deaths reported to the EMCDDA had undergone an autopsy. As expected 
the more non-specific codes e.g. the F codes had a higher percentage of deaths 
without autopsy.    
 
 
 
Figure 7: Trends in the number of drug related deaths according to selection B and 
selection D (Source: EMCDDA statistical bulletin) 
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Table 14: DRDs with or without autopsy according to selection B in 2012 and 2013  
 
Use of X44/X64/Y14 codes 
 
The use of X44/X64/Y14 codes follows the WHO ICD-10 updates and is reported to 
the EMCDDA as per Selection B protocol. Over half (61%) of X44/X64/Y14 cases fall 
within the criteria for reporting according to selection B (table 15). These may 
include cases of T codes combined with F10-F19. 
 
 
 
Table 15: deaths with or without autopsy due to X44/X64/Y14 in 2012/2013 in 
selection B and not in selection B 
 
Cases coded under X44/X64/Y14 but which do not fall under selection B include 
cases with specific T codes and others with T50 as per table 16 below. 45 cases or 
35% are coded as T50.9 and most of these (62%) have not undergone an autopsy. As 
seen in other country reports cases placed under this code may be those in which 
not enough information is available to be able to identify and therefore code the 
drug specifically or the type of drug was specified, but is classified among the "rest" 
category in T50.9 as no specific code exist. 
  
 
   
 
Table 16: deaths coded as X44/X64/Y14 in 2012/2013 not in selection B 
 
Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes related to drugs i.e. X49 and X69 and Y19 as 
well as unspecified codes in general i.e. R96, R98 and R99 in the age groups 15-64 
2012/2013
autopsy no autopsy
F codes 9 38
X41/X61/Y11 4 0
X42/X62/Y12 178 47
X44/X64/Y14 165 31
Total 356 116
Selection B
2012/2013
autopsy no autopsy autopsy no autopsy
X44/X64/Y14 165 31 57 70
Selection B Not selection B
X44/X64/Y14 not selection B Number in 2012/13
Specific T code 60
T 50 61
Other 6
Total 127
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years was undertaken (tables 17).  There were no cases coded as X49 or Y19 and 
very few cases under X69 reflecting no loss of cases to these codes. The more 
general codes particularly R99 accounted for a quite a large percentage of deaths.  A 
number of these cases have not yet been reported to the GMR and some of them 
will be reported later. Therefore data will become more accurate and complete over 
time and the most recent year will have the highest share of cases with R99. It is very 
difficult to know if there would be any drug related deaths amongst these cases 
 
 
 
 
Table 17: Percentages of unspecified causes of death by ICD code and age group in 
20125 
 
Discussion and conclusion 
 
In 2013 the drug-induced mortality rate among adults (aged 15–64 years) was 55.1 
deaths per million, compared to the European average of 19.2 deaths per million. 
The General Mortality Register in Denmark is very comprehensive and picks up all 
cases of drug related deaths undergoing an autopsy as all autopsy reports are 
forwarded to the GMR.   
 
Denmark is one of the few countries which has fully implemented ICD-10 updates 
related to drug related deaths. Most cases coded under X44/X64/Y14 which fit the 
criteria under selection B fall under T40 codes often in combination with another 
code.   
 
In other cases of X44/X64/Y14 which are not included in selection B, a high 
percentage of cases have T50.9 as the main injury code which is non specific. Often 
in these cases this is the only T code given. As described previously this may be 
either due to the substance causing death is not known or no specific T code is 
available for that substance/s. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
R98 0.00 2.75 0.91 0.68 0.39 1.27 0.78 0.93 1.04 0.79
R99 3.08 3.67 7.27 6.16 7.00 4.65 3.88 4.35 3.80 4.62
X69 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.03
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5.3 France 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in France 
 
In collaboration with the French National Focal Point (ODFT): Anne-Claire Brisacier 
 
Background 
 
France has two main sources of information for drug related mortality statistics 
namely the General Mortality Register and the Special Register.  The General 
Mortality Registry (INSERM CépiDc) has national coverage and reports drug related 
deaths to the EMCDDA according to selection B (limited ICD 10 codes). The Special 
Register (DRAMES), is maintained by the Agency for Medicines (ANSM) which 
records data from autopsies but does not have national coverage. The main aim of 
this register is to study poly drug use and the association of substances leading to 
death. France does not report according to selection D anymore. 
 
Estimation of the number of Drug related Deaths 
 
Drug related deaths reported according to selection B are considered to be 
underestimated.   
Requests for autopsies are not systematic and depend on the prosecutor’s decision. 
Forensic analysis may be canceled for external reason (budget constraints). Also 
some forensic physicians do not transmit data from legal investigation although the 
results of these analyses are supposed to be sent to the GMR.  Often forensic 
laboratories cite confidentiality of legal investigation as the reason for this. In that 
case, the previous temporary "unknown or ill-defined causes of death" code will 
remain as such. Furthermore, the substances responsible for death are often poorly 
detailed, since the most frequently seen wording is that of “addiction” or “opioid 
overdose” without any further specifications. Finally this data only becomes 
available two years after they are recorded. 
  
France reports according to selection B but ICD 10 updates have only been partially 
implemented because T codes are not included in the GMR database since the 
names of substances are often not specified on the death certificate. Therefore the 
ICD-10 codes reported according to selection B to the EMCDDA are F11-F12, F14-
F16, F19, X42, X62 and Y12.   
 
A new version of the French death certificate will be available in October 2016. With 
the new death certificate, it will be possible to send a complementary form to 
update the certificate, without doing another. This should permit the forensic 
laboratories to add information, such as toxicological results. 
 
The SR is based on a convention signed between the ANSM and some toxicological 
experts or forensic laboratories and willing to participate. These laboratories 
transmit to the ANSM a short sheet with basic information. This system is not 
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exhaustive (it covers 60% of the activity of all toxicology laboratories in 2008) and is 
mainly useful for providing information on the substances involved. 
 
Use of X44/X64/Y14 and other ICD-10 codes in reporting drug related deaths 
 
Since the GMR does not include toxicological information and T codes due to 
frequent absence of specific information required to code using T codes reporting of 
X44/X64/Y14 is not reported to the EMCDDA. In France X44/X64/Y14 are mainly use 
to code ‘Accidental poisoning by and exposure to other and unspecified drugs, 
medicaments and biological substances’. Therefore the lack of information on the 
death certificates has impeded France from implementing the ICD-10 updates. 
 
Analysis of DRDs in France 
 
Trends in DRDs 
 
During the first years of reporting using both selection B and selection D a similar 
trend in DRDs was observed however from the year 2000 deaths according to 
selection D were much less then selection B, and soon after selection D was no 
longer used to report DRDs (figure 8). Trends according to ICD 10 codes reported in 
selection B do not show any particular changes around 2006 when ICD 10 updates 
should have been implemented (figure 9). Only deaths with F codes (F11-F12, F14-
F16, F19) and X42/X62/Y12 are reported, missing any other cases in the other 2 
groups: X41/X61/Y11 and X44/X64/Y14.  
 
  
 
Figure 8: Trends in DRDs according to selection B and selection D6 
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Figure 9: Trends in DRDs according to ICD 10 codes reported in selection B6 
 
 
Loss of DRDs due to non-reporting of X41/X61/Y11 and X44/X64/Y14  
 
According to the analysis undertaken by the French National Focal Point (see annex 
C) when reviewing all cases of X41/X61/Y11 as well as X44/X64/Y14 an additional 76 
cases could be considered as DRDs according to selection B in 2012. These were not 
normally included as since France do not include T codes, reporting of all 
X41/X61/Y11 and X44/X64/Y14 should not be included as this would represent an 
overestimation. X41/X61/Y11 accounted for 110 deaths and X44/X64/Y14 accounted 
for 978 deaths in 2012.  However also according to this analysis 51 deaths should not 
have been included in DRDs reported under selection B when reporting deaths due 
to ICD-10 codes X42/X62/Y12 and F codes since these deaths were considered, 
deaths of drug users not related to an overdose or deaths by opiates overdose out of 
drug addiction or use of drugs (Table 18). Finally this analysis would have included 
another 48 other cases involving a drug that could be also considered overdoses but 
don’t appear as such because of the choice of another underlying cause of death. If 
one had to consider all this, one can estimate that there is an underestimation of at 
least 73 deaths (or 28%) due to coding issues.   
 
 
 
Table 18: DRDs according to ICD 10 codes that would fit selection B and other codes 
in 2012 
 
 
Codes According to selection B To include To exclude Total
F 140 0 26 114
X41/X61/Y11 0 11 0 11
X42/X62/Y12 124 0 25 99
X44/X64/Y14 0 65 0 65
Other codes 0 48 0 48
Total 264 124 51 337
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The use or non-use of T codes 
 
Although a number of DRDs may have information on the substance/s resulting in 
the death, currently France do not include T codes as often the information provided 
on the drug may be nonspecific. According to our analysis in the X42/X62/Y12, 36% 
were considered as non-specific and coded as ‘overdoses’ in the context of drug 
addiction. In the codes X41/X61/Y11, 30% were considered as psychotropics 
unspecified and would be coded as T43.9. However in both groups there were a 
number of cases in which the specific drug was not named but were mentioned in a 
more generic group e.g. opiates, neuroleptics e.t.c. Also while a number of cases had 
a named drug it was difficult to know if a code existed for these cases due to 
language barriers. In the case of X44/X64/Y14 based on a sample analysed: 78% 
were non-specific in the text written.   
Also there were few cases in the X42/X62/Y12 as well as X41/X61/Y11 were multiple 
drugs from different groups were present and should possibly be coded in the 
X44/X64/Y14 category. 
 
 
 
Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes related to drugs i.e. X49 and X69 and Y19 as 
well as unspecified codes in general i.e. R96, R98 and R99 was undertaken (table 19).  
X49/X69/Y19 accounted for a very low percentage of deaths reflecting little loss of 
cases to these codes. The more general codes particularly R99 but also somewhat 
R96 accounted for a large percentage of deaths and particularly in the age groups 
15-44 could account for some DRDs. 
 
 
 
 
Table 19: Percentage of deaths due to non-specific ICD 10 codes in 20125 
 
Discussion and Conclusion  
 
The estimated drug-induced mortality rate among adults (aged 15–64) is 5.4 deaths 
per million in 2012 (according to the most recent data available from the French 
mortality register), much less than the most recent European average of 19.2 deaths 
per million in 2012. Since France do not report according to the full protocol of 
selection B there are some cases which are lost as they are coded in the 
X41/X61/Y11 and X44/X64/Y14 ICD 10 codes. The non-specific ICD-10 codes 
particularly R99 account for quite a high percentage of deaths and especially in the 
ICD-10 code Total <1 1-4 5-14 15-24 25-34 35-44 45-54 55-64 65-74 75-84 85-94 95+
'X49 0.02 0.00 0.00 0.00 0.17 0.37 0.18 0.05 0.02 0.01 0.00 0.00 0.00
'X69 0.01 0.00 0.00 0.00 0.07 0.13 0.11 0.07 0.03 0.01 0.01 0.00 0.00
'Y19 0.00 0.03 0.00 0.15 0.14 0.11 0.03 0.02 0.01 0.00 0.00 0.00 0.00
'R96 0.32 0.00 2.70 0.15 0.21 0.50 0.62 0.62 0.45 0.39 0.30 0.24 0.17
'R98 0.12 0.03 0.00 0.00 0.21 0.48 0.38 0.44 0.25 0.16 0.08 0.04 0.04
'R99 4.30 7.08 7.37 8.85 10.67 11.57 9.32 6.90 5.11 4.13 3.55 3.60 4.83
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age groups 15-44 could possibly include some DRDs. The fact that autopsies are not 
systematically done would explain this high figure. Infact according to French data, 
70% of deaths in the F11-F12, F14-F16, F19, X42, X62, Y12, X44, X64 and Y14 groups 
did not undergo autopsy in 2013.   
 
A study carried out by Eric Janssen in 2011 undertook different capture-recapture 
techniques using different sources of DRDs and it was estimated that there was at 
least 30% underestimation of DRDs in France. It is thought that estimates of DRDs 
based on this and other techniques should be developed to get a better estimate of 
DRDs in France. 
 
Also although specificity of drugs may not be routinely available an effort to start 
including T codes would be useful and may lead to the capture of more DRDs. 
 
The use of X44/X64/Y14 according to the ICD-10 update but however not including T 
codes would lead to a number of drug related deaths previously coded in the 
X42/X62/Y12 and X41/X61/Y11 categories moving to the more non specific code 
X44/X64/Y14 and would not be captured under Selection B.      
 
5.4 Germany 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Germany 
In collaboration with the German National Focal Point: Axel Heinemann and Esther Dammer 
 
 
Background 
 
In Germany drug related deaths are reported to the EMCDDA from two main 
sources: the General Mortality Register which is based in the Federal Statistical 
Office (Statistisches Bundesamt) and reports DRDs according to selection B and the 
Police Register of the Federal Office of Criminal Investigation 
(Bundeskriminalamt/BKA) which reports DRDs according to the National definition.  
The national definition includes deaths following intentional or unintentional 
overdose, deaths as a result of long-term abuse, deaths as a result of suicide and 
deaths as a result of fatal accidents suffered by people under the influence of drugs. 
 
ICD-Codes 
 
The ICD codes used by the GMR to report DRDs according to selection B are: F codes, 
X41, X42, X44, X61, X62, X64, Y11, Y12, Y14 and associated T-codes. However most 
cases are still coded under F codes and therefore T codes are not so frequently used. 
In 2014, T-codes were recorded in only 33.0% of registered cases.  
Though the ICD updates and priority list related to DRDs has been introduced there 
is no evaluation how regularly it has been applied by the persons responsible for the 
coding in the 16 Bundesländer.  
 
Analysis of DRDs in Germany  
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General Trends 
 
Although on average more drug related deaths are reported according to the 
national definition then according to selection B, the trend according to both sources 
is similar (figure 10).  
 
 
 
 
 
Figure 10: Trends in the number of drug related deaths according to selection B and 
national definition6 
 
Trends by ICD-10 codes 
 
Trends in the number of drug related deaths according to ICD codes reported in 
selection B show that F codes are responsible for most DRDs followed by 
X42/X62/Y12 codes. Very few deaths are reported using X41/X61/Y11 codes and 
X44/X64/Y14 codes. The ICD 10 update related to DRDs in 2002/2003 to be 
implemented in 2006 had little or no effect on the reporting of deaths according to 
the different ICD codes as seen in figure 11.    
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Figure 11: Trends in the number of drug related deaths according to ICD codes 
reported in selection B6 
 
As described previously most DRDs are coded using F codes (see table 20). Quite a 
large number of deaths are coded using X41/X61/Y11, however these are often 
combined with specific T codes which do not fit the criteria for selection B. On the 
other hand many deaths coded with X44/X64/Y14 are in combination with T50.9 and 
could therefore include DRDs which would fit the selection B criteria. Only few 
deaths coded as X49/X69/Y19 with non-specific T codes are found.      
 
 
*In combination with specific T codes as specified in annex 2 
 
Table 20: number of DRDs according to selection B or not in persons aged 15-64 
years in 2014 
 
In 2014 in the age group 15-64 years, 468 deaths were coded as X44/X64/Y14 and 
T50.9. T50.9 represents ‘other unspecified drugs, medicaments and biological 
substances’. As seen in other country reports, cases placed under this code may be 
those in which not enough information is available to be able to identify and 
therefore code the drug specifically or the type of drug was specified, but is classified 
among the "rest" category in T50.9 as no specific code exist. 
 
Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes in general i.e. I46.9, R96, R98 and R99 in the 
age groups 15-64 years was undertaken (table 21).  Code R99 accounted for quite a 
high percentage of deaths in these age groups; however it is very difficult to know if 
there would be any drug related deaths amongst these cases.   
 
code Included in selection B Not included in selection B
F codes 769 9
X41/X61/Y11* 9 104
X42/X62/Y12* 319 7
X44/X64/Y14* 21 479
X49/X69/Y19* 0 7
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Table 21: Percentages of unspecified causes of death by ICD code and age group in 
20135 
 
 
Discussion and conclusion 
 
In 2014 the drug-induced mortality rate among adults (aged 15–64 years) was 18.6 
deaths per million in Germany, compared to the European average of 19.2 deaths 
per million. Though the General Mortality Register in Germany includes T codes and 
has also implemented the ICD-10 updates to a certain extent, many drug related 
deaths are still coded using F codes. In other cases of X44/X64/Y14 which are not 
included in selection B, a high percentage of cases have T50.9 as the main injury 
code which is non-specific. As described previously this may be either due to the 
substance causing death being unknown or the unavailability of a specific T code for 
that substance/s and may result in a degree of under-reporting of drug related 
deaths. 
 
The use of two sources of information i.e. in this case the general mortality registry 
and that according to the national definition is useful especially in monitoring trends, 
because even though the two sources don’t report the same number of DRDs every 
year, trends follow a similar pattern.    
 
 
5.5 Italy 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Italy 
In collaboration with the Italian National Focal Point: Roberta Crialesi and Francesco Grippo 
 
Background 
 
In Italy, data on drug related deaths (DRDs) is reported both according to selection B 
and according to selection D however the special register (i.e. selection D) is the 
main source of data on drug related deaths (DRDs). The Special Register of the DCSA 
(Central Directorate for Antidrug Services) is based on information obtained from 
police reports. The information on the substance involved is based on circumstantial 
evidence. Autopsy findings are not included in this data source. 
The General Mortality Register resides in ISTAT (Italian National Institute of 
Statistics) and is based on the death certificate, coded according to ICD-10 and 
includes T codes. Not always autopsy findings are used for the cause of death 
certification.   
 
 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
I469 0.30 0.33 0.56 0.42 0.40 0.48 0.38 0.45 0.43 0.34
R96 0.10 0.00 0.00 0.00 0.06 0.00 0.05 0.04 0.03 0.03
R98 1.02 1.17 1.95 1.62 2.51 2.41 2.28 2.02 1.73 1.41
R99 2.84 4.68 4.46 4.82 5.11 4.52 4.32 3.78 3.34 2.72
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General Trends 
 
Both the main source of reporting i.e. selection D and the other source of reporting, 
selection B, show a very similar trend in deaths due to drugs, with the main source 
reporting more deaths every year. There has been a downward trend in DRDs in Italy 
for many years, which now seems to be leveling off.  
 
 
 
Figure 12: Trends in the number of drug related deaths according to selection B and 
selection D6 
 
ICD-10 codes 
 
As per table 22 below the main codes used in reporting DRDs according to selection 
B were F codes and X42/X62/Y12 codes. There were few reported deaths due to 
X41/X61/Y11 codes however X44/X64/Y14 codes were only very occasionally used in 
reporting DRDs according to selection B.  Quite a large number of deaths reported 
under X44/X64/Y14 and X49/X69/Y19 which are not reported to the EMCDDA had a 
corresponding T code which was unspecified i.e. T50.9.  
 
 
*Those not according to EMCDDA definition are in combination with T50.9 only 
 
Table 22: Number of drug related deaths according to a selection of ICD codes  
 
 
 
 
CODE EMCDDA NOT EMCDDA
F 397 1
X41,X61,Y11 22 84
X42,X62,Y12 345 0
X44,X64,Y14* 3 224
X49,X69,Y19* 0 8
2011-2013
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Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes related to drugs i.e. X44, X64 and Y14 as well 
as X49, X69 and Y19 as well as unspecified codes in general i.e. I469, R96, R98 and 
R99 in the age groups 15-64 years was undertaken (table 23).  X44/X64/Y14 and 
X49/X69/Y19 accounted for a very low percentage of all deaths in these age groups, 
however as seen in table 22 above, many of these deaths are associated with T50.9 
which may include drug related death cases but are unspecified. The more general 
codes particularly R99 but also somewhat I46.9 accounted for a larger percentage of 
deaths. It is very difficult to know if there would be any drug related deaths amongst 
these cases and further analysis involving other sources of information would be 
required to possibly decipher these cases, since the death certificate does not 
contain any further information on the cause of death. 
 
 
 
 
Table 23: Percentages of unspecified causes of death by ICD code and age group in 
20125 
 
Discussion and conclusion 
 
In 2014 the drug-induced mortality rate among adults (aged 15–64 years) in Italy was 
8 deaths per million, compared to the European average of 19.2 deaths per million. 
Trends in drug related deaths follow a similar pattern when reported according to 
selection D or selection B, with only minor discrepancies. Though Italy includes T 
codes in coding of drug related deaths, very few cases under X44/X64/Y14 are 
included under selection B with many cases coded in combination with T50.9. No 
further information is available as to what cases are placed under T50.9 however as 
with other countries this may be either due to the substance causing death is not 
known or no specific T code is available for that substance/s. 
 
In countries which code all drugs involved in the death, multiple cause analysis can 
be undertaken to evaluate in more detail the trends in the drugs involved in drug 
related deaths. Also in countries where this is possible it would be interesting to try 
to analyse further the deaths especially in the younger age groups which were given 
an unspecified code such as R99.   
 
 
 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
I469 1.59 1.10 1.84 2.20 2.02 1.93 1.72 1.33 1.28 0.98
R96 0.00 0.37 0.15 0.00 0.27 0.16 0.10 0.10 0.07 0.06
R98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
R99 4.34 5.67 4.53 5.18 3.93 3.14 1.71 1.11 0.82 0.49
X44 0.14 0.09 0.08 0.17 0.10 0.10 0.02 0.03 0.00 0.01
X49 0.00 0.27 0.77 0.90 0.57 0.49 0.16 0.09 0.02 0.02
X64 0.00 0.00 0.15 0.23 0.13 0.18 0.12 0.17 0.07 0.02
X69 0.00 0.18 0.08 0.11 0.10 0.12 0.09 0.05 0.03 0.02
Y19 0.00 0.00 0.08 0.00 0.00 0.00 0.01 0.00 0.00 0.00
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5.6 Norway 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Norway 
In collaboration with the Norwegian National Focal Point: Thomas Clausen and Christian 
Lycke Ellingsen and Vigdis Vindenes 
 
 
Background 
 
In Norway the General Mortality Register (GMR) is the main source of data on drug 
related deaths (DRDs). Until 2009 Norway also had a special register which was 
based on police reported overdoses/drug related deaths, but this does not operate 
anymore. The General Mortality Register obtains a copy of all forensic and medical 
autopsies however the detail of information received varies. Since it receives an 
autopsy report for almost all drug related deaths, its coverage is considered very 
good, however about 10% of cases reported to EMCDDA as DRDs are not based upon 
autopsies, but only a general doctor would have issued the death certificate. 
 
In Norway the toxicology examination results are sent to the medical forensic 
examiner only, and not to the GMR. The GMR therefore only receives toxicology 
codes that the forensic examiner finds relevant to include in his/her report. Also the 
toxicology laboratory, does not receive back the conclusions from forensic examiner, 
and therefore cannot directly use their data to infer cause of death, only detection of 
the substances. A specific project where toxicology data and forensic examiner data 
are to be linked is underway, but not yet to be standard routine.  
  
Toxicology in Norway is performed with a standard examination program, including 
more than 100 substances, but this may be extended due to circumstances, and 
specifically requested additional analysis. Most toxicological tests are performed at 
Norwegian Institute of Public Health in Oslo, and the other forensic lab is at St. Olavs 
Hospital Trondheim University Hospital. 
 
Analytic methods 
 
The analytical screening in Norway includes a large number of medicinal and illicit 
drugs, using peripheral blood as the preferred matrix; a selection of drugs are 
analysed by ultra-high performance liquid chromatography tandem mass 
spectrometry (UHPLC-MS/MS) and additionally a large number of medical 
substances are first analysed by an in-house UHPLC-MS/MS-method and later by 
targeted UHPLC-QTOF-MS (an ultra-performance liquid chromatography 
quadrupole-time-of-flight mass spectrometry) method. All positive screening results 
are confirmed with additional chromatographic methods.  
 
Estimation of the number of drug related deaths 
 
Based on the available information from death certificates and autopsy reports 
(where applicable), the GMR codes the deaths semi-automatically with the data 
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program IRIS/ACME. For all deaths with an external cause (injuries, poisonings etc), 
there is a manual evaluation. The GMR codes the final/definitive cause of death 
manually based on the available information, primarily autopsy reports. When the 
GMR receives the reports from an autopsy, the content varies quite a bit, from 
including the full report, also including all toxicology findings, to other cases with 
only the main findings and codes, without all the details.Only information from the 
post-mortem report that has relevance for the cause of death are coded into the 
GMR. The full post-mortem report is scanned and stored, but relevant information 
for the coding is retrieved manually and punched. Normally the conclusion from the 
forensic report will be the final cause of death coded by the GMR. The GMR 
performs the final coding based on ICD-10 manuals. The database also stores text of 
causes of death.  Annually there are about 1-2% of deaths that do not have an issued 
death certificate or post-mortem report. These are registered as ‘unknown cause’, 
many of these deaths took place abroad (Norwegian citizens). 
 
The General Mortality Register reports according to selection B and has 
implemented all ICD-10 updates related to drug related deaths. 
 
Use of X44 and other ICD-10 codes in reporting drug related deaths 
 
X44 ("Accidental poisoning by and exposure to other and unspecified drugs, 
medicaments and biological substances") is used in accidental poisonings either:  
1) by other specified substances, not covered in the other groups (X40-X43),  
2)by a combination of substances, where no substance is clearly stated as the main 
intoxicant; or 
 3)where the particular type of substance is unknown (but supposed to be a 
drug/medicament. 
 
T50.9 ("Poisoning: Other and unspecified drugs, medicaments and biological 
substances") is used either when the substance involved is ‘specified’, but not 
covered in the other groups (T36-T50.8) or when the substance is unknown (but 
supposed to be a drug/medicament).  During recent years the number of T50.9 
codes has been reduced and the rate of these deaths based on autopsy has 
increased during the same period, indicating a trend towards more specific and 
improved coding practice where other and alternative codes are increasingly applied 
when appropriate. 
 
 
Analysis of DRDs in Norway  
 
General Trends 
 
Both the main source of reporting i.e. selection B and the other source of reporting, 
selection D, show a similar trend in deaths due to drugs, with the main source 
reporting more deaths every year. Until 2002 the national definition did not include 
"intentional poisoning" (ICD codes: X61, X62). From 2003 "Selection B" has become 
the national definition. In the case of selection D, these include cases in which the 
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police had knowledge of the death, but does not include suicide with drugs, since it 
is a different method of data collection and different definition, both contributing to 
differences in estimates, although trends were largely similar. 
 
 
 
 
Figure 13: Trends in the number of drug related deaths according to selection B and 
selection D6 
 
Trends by ICD-10 codes 
 
Trends in the number of drug related deaths according to ICD codes reported in 
selection B shows that codes X42/X62/Y12 are responsible for most DRDs. 
X44/X64/Y14 codes have been in use and reported to the EMCDDA for many years 
even before the ICD-10 updates in 2006. Infact the ICD 10 update related to DRDs in 
2002/2003 to be implemented in 2006 had no effect on the reporting of deaths 
according to the different ICD codes below, up to the year data according to ICD 
codes was reported to EMCDDA (i.e from 2003) as per figure 14 below.    
 
 
 
 
Figure 14: Trends in the number of drug related deaths according to ICD codes 
reported in selection B6 
 
The overall percentage of drug related deaths undergoing autopsy in Norway is high. 
Most cases which do not undergo autopsy are in the F codes as would be expected 
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as in these cases there would be limited information on the cause of death. However 
these account for a small percentage of deaths. 
 
 
 
 
Table 24: Number and percentage of DRDs according to ICD 10 code reported in 
selection B and percentage in each group undergoing autopsy in 2012-2014 
 
Use of X44/X64/Y14 codes 
 
The use of X44/X64/Y14 codes follows the WHO ICD-10 updates and is reported to 
the EMCDDA as per Selection B protocol. Less than half of X44/X64/Y14 cases fall 
within the criteria for reporting according to selection B (Table 25). 
 
 
 
Table 25: Number and percentage of X44/X64/Y14cases included in cases reported in 
selection B 
 
The main injury code reported with X44/X64/Y14 which are included in selection B 
are as per table 26 below. X44/X64/Y14 codes reported to the EMCDDA include 
deaths with at least two T codes or more, or a T code and an F code with at least one 
drug (T or F code) which is according to selection B.  However this drug as per 
selection B may not necessarily be the main injury code.    
 
 
 
Table 26: Number of deaths in the X44/X64/Y14 categories (2012-2014) included in 
selection B and main injury code 
 
 
 
 Of the cases which do not fit the criteria over half the cases are coded as 
X44/X64/Y14 and T50.9 which represents ‘other unspecified drugs, medicaments 
ICD 10 code number and % of 
drds in 2012
Percentage 
with autopsy 
in 2012
number and % of 
drds in 2013
Percentage 
with autopsy in 
2013
number and % 
of drds in 2014
Percentage 
with autopsy 
in 2014
F codes 11.8% (n=32) 53% 9.8% (n=25) 36% 5.4% (n=15) 20%
X41/X61/Y11 7.3% (n=20) 100% 8.2% (n=21) 100% 6.8% (n=19) 94.7%
X42/X62/Y12 66.1% (n=179) 90.50% 68.6 %(n=175) 93.10% 71.2% (n=198) 95.5%
X44/X64/Y14 14.8% (n=40) 87.50% 13.3% (n=34) 88.20% 16.5% (n=46) 91.3%
Total 100% (n=271) 86.30% 100% (n=255) 87.50% 100% (n=278) 90.6%
Year X44/X64/Y14 included X44/X64/Y14 not included Total
2012 40 (37.7%) 66 (62.3%) 106
2013 34 (43.0%) 45 (57.0%) 79
2014 46 (47.4%) 51 (52.6%) 97
Main injury code (2012-2014) number
T40 codes 88
T43 codes 9
T50 codes and other 23
Total 120
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and biological substances’ even though some of them have undergone an autopsy 
(tables 27,28,29). There are several possible reasons for this which includes:   
a) An autopsy was performed, but no toxicological analysis was performed (very 
rarely in forensic cases, may be seen in hospital autopsies);  
b) A toxicological analysis was performed, but no drug was clearly identified. 
Nevertheless the cause of death was stated as accidental poisoning. This may be the 
case in severe decomposition or when the person dies from late effects of the 
poisoning; 
c) The type of drug was not clearly stated on the autopsy report (even if the results 
of the toxicological analysis was known to the pathologist), and there was no 
response to the GMR query; 
d) The type of drug was specified, but is classified among the "rest" category in 
T50.9;  
 
 
 
 
Table 27: T codes associated with X44/X64/Y14 not included in selection B in 2012  
 
 
 
Table 28: T codes associated with X44/X64/Y14 not included in selection B in 2013  
 
 
 
Table 29: T codes associated with X44/X64/Y14 not included in selection B in 2014 
 
 
Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes related to drugs i.e. X49 and X69 and Y19 as 
well as unspecified codes in general i.e. R96, R98 and R99 in the age groups 15-64 
years was undertaken (tables 30-32).  X49/X69/Y19 accounted for a very low 
percentage of deaths reflecting no loss of cases to these codes. The more general 
codes particularly R99 but also somewhat R96 accounted for a large percentage of 
T codes associated 
with X44/X64/Y14 with autopsy without autopsy Total
Specified T codes 19 8 27 (40.9%)
T50.9 27 12 39 (59.1%)
Total 46 20 66 (100%)
2012
T codes associated 
with X44/X64/Y14 with autopsy without autopsy Total
Specified T codes 9 6 15 (33.3%)
T50.9 12 18 30 (66.7%)
Total 21 24 45 (100%)
2013
T codes associated 
with X44/X64/Y14 with autopsy without autopsy Total
Specified T codes 12 11 23 (45.1%)
T50.9 13 15 28 (54.9%)
Total 25 26 51 (100%)
2014
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deaths particularly in 2014 but also in 2013. It is very difficult to know if there would 
be any drug related deaths amongst these cases but other possible causes include 
deaths of Norwegian residents abroad with no access to the cause of death and 
deaths in which the additional information is still being sought and would then 
provide a clearer cause of death later on.   
 
 
 
Table 30: Percentages of unspecified causes of death by ICD code and age group in 
2012 
 
 
  
Table 31: Percentages of unspecified causes of death by ICD code and age group in 
2013 
 
 
 
Table 32: Percentages of unspecified causes of death by ICD code and age group in 
2014 
 
 
Discussion and conclusion 
 
In 2013 the drug-induced mortality rate among adults (aged 15–64 years) was 67.8 
deaths per million, compared to the European average of 19.2 deaths per million. 
Among confirmed cases of overdose deaths, the rate of autopsy is high, but the 
autopsy rate differs between districts. The General Mortality Register in Norway is 
very comprehensive and picks up all cases of drug related deaths undergoing an 
autopsy as all autopsy reports are forwarded to the GMR.  The GMR is also a ‘live’ 
database allowing additional information to be included after the formal year of 
publication. For this reason the EMCDDA may need to request updated annual data 
2-3 following the original data request. 
 
Norway is one of the few countries which has fully implemented ICD-10 updates 
related to drug related deaths. Most cases coded under X44/X64/Y14 which fit the 
2012 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
R960 0.00 0.00 0.00 0.00 0.77 0.26 1.56 1.20 1.19 1.68
R98 0.00 0.00 0.00 0.00 0.00 0.26 0.00 0.00 0.07 0.14
R99 2.56 0.00 0.69 1.08 1.54 2.37 0.17 1.41 0.89 0.98
X49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00
X69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.00 0.00
2013 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
R960 0.00 2.30 2.11 0.00 1.61 1.18 1.52 1.92 3.36 2.43
R98 0.00 0.00 0.00 0.00 0.00 0.39 0.51 0.87 0.22 0.21
R99 0.00 1.15 2.82 3.73 3.76 3.54 2.28 5.24 3.47 2.64
X49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.00 0.00
X69 0.00 2.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2014 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
R960 0.00 0.74 0.61 0.53 1.21 0.58 0.17 1.10 0.93 1.56
R98 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.11 0.00 0.16
R99 1.45 0.74 6.10 2.11 4.05 1.74 3.66 1.65 2.16 1.92
X49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
X69 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.11 0.00 0.00
39 
 
criteria under selection B fall under T40 codes. However in other cases the main 
injury code is non-specific e.g. T50.9 as often the other code would be an F code.  
 
In other cases of X44/X64/Y14 which are not included in selection B, a high 
percentage of cases have T50.9 as the main injury code which is non specific. Often 
in these cases this is the only T code given. As described previously this may be 
either due to the substance causing death is not known or no specific T code is 
available for that substance/s. 
 
In countries which code all drugs involved in the death, multiple cause analysis can 
be undertaken to evaluate in more detail the trends in the drugs involved in drug 
related deaths.    
 
 
5.7 Poland 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Poland 
In collaboration with National Polish Focal Point Artur Malczewski and Janusz Sierosławski 
 
 
Background 
 
In Poland, data on drug related deaths (DRDs) is based on data from the Central 
Statistics Office (GUS). Data is reported according to their national definition and not 
according to selection B or selection D. It is based on ICD-10 and includes the 
following ICD 10 codes: F11-12, F14-16, F19, X42, X44, X62, X64, Y12, Y14. T codes 
are not available.  
 
 
General Trends 
 
The trend in drug related deaths in Poland showed an initial upward trend in the 
1990s till 2002 followed by a downward and then stable trend.  
 
 
 
Figure 15: Trends in the number of drug related deaths according to national 
definition6  
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ICD-10 codes 
 
Poland report deaths due to drugs using the following ICD-10 codes: F11-12, F14-16, 
F19, X42, X44, X62, X64, Y12, Y14. T codes are not available. The use of F codes has 
always been low even before the icd-10 updates. Also X44/X64/Y14 are used 
extensively and though there is some loss of reporting due to X41/X61/Y11 codes 
not being reported, on the other hand there might be over-reporting since all 
X44/X64/Y14 codes are reported. X49/X69/Y19 has been included in the graph below 
as quite a few drug related deaths are given this ICD code in Poland and some under-
reporting may result from this in the data given to the EMCDDA. Recently figures for 
these codes have been quite small.        
 
 
 
Figure 16: Number of drug related deaths in 15-64 years according to a selection of 
ICD 10 codes5   
 
 
Unspecified ICD-10 codes  
 
An analysis of unspecified ICD-10 codes in general i.e. I469, R96, R98 and R99 in the 
age groups 15-64 years was undertaken (table 33).  These non specific codes account 
for a large percentage of deaths especially if taken together however it is very 
difficult to know if there would be any drug related deaths amongst these cases and 
further in depth analysis would be required to possibly decipher these cases, 
however often the information is not available. 
 
 
 
Table 33: Percentages of unspecified causes of death by ICD code and age group in 
20135 
 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
I469 0.30 0.80 0.92 1.23 1.66 1.95 2.12 1.81 1.78 1.54
R96 0.51 1.41 2.52 3.68 3.94 4.17 3.45 2.87 2.10 1.54
R98 1.62 2.21 2.76 3.11 3.69 3.91 3.33 3.14 2.37 1.93
R99 2.33 2.34 2.72 4.26 4.67 3.87 3.63 3.35 2.83 2.35
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Discussion and conclusion 
 
In 2013 the drug-induced mortality rate among adults (aged 15–64 years) in Poland 
was 8.5 deaths per million, compared to the European average of 19.2 deaths per 
million. Poland does not report drug related deaths according to selection B or 
selection D to the EMCDDA also since it does not have T codes. Countries are 
encouraged to start using T codes as this adds greatly to the specificity of drug 
related deaths. It would also allow the implementation of ICD-10 updates in full.  
Also in countries where this is possible it would be interesting to try to analyse 
further the deaths especially in the younger age groups which were given an 
unspecified code such as R99.   
 
5.8 Spain 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in Spain 
In collaboration with the Spanish Observatory on Drugs. Alvarez Elena, Llorens Noelia, 
Sendino Rosario.  
 
 
 
Background 
 
Spain currently has, fundamentally, two sources of information for drug-induced 
deaths statistics namely a Specific Register of Mortality due to Acute Reaction to 
Drugs, administered by the Spanish National Focal Point and a General Mortality 
Register, managed by the National Statistics Institute.  
 
The primary sources of information for the Special Register are the Forensic 
Anatomical Institutes, Forensic Physicians, National Toxicology Institute and 
University Legal Medicine Departments which send the data to their regions and 
these in turn send them to the database of the Spanish Observatory on Drugs and 
Drug Addictions of the DGPNSD. The Special Register covers persons aged 10 to 64 
years and has around 50% population coverage and includes toxicology information.  
 
The General Mortality Register resides with the Spanish National Statistics Institute 
(INE) and records the causes of death classified according to the World Health 
Organisation’s International Classification of Diseases (ICD). The INE’s mortality 
databases are administered in collaboration with the different regions. The primary 
source of information is the Civil Registers, which send the death reports to the INE’s 
regional delegations on a monthly basis. Spanish GMR doesn´t record T codes and 
doesn´t include toxicology information. 
 
Estimation of the number of Drug related deaths 
 
  
The two sources of information mentioned above namely the Specific Mortality 
Register and the General Mortality Register have certain limitations and in order to 
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minimise these, an estimation of mortality is made using the information of both 
registers. 
The Specific Mortality Register provides data on deaths from the reports of deaths 
due to drugs in some regions; however though it is a detailed register it does not 
have national coverage. On the other hand the General Mortality Register does have 
complete nationwide coverage and, although the quality of the register is good, 
detailed information on drug related deaths is not always available. It is estimated 
that, in Spain, deaths for drugs from the General Mortality Register are 
underestimated by 40%. Consequently, in order to estimate the number of drug-
related deaths at the national level, the specificity of the Specific Register is 
combined with the greater coverage of the General register.  
 
Use of X44 and other ICD-10 codes in reporting drug related deaths 
 
Since the GMR does not include toxicological information and T codes due to 
absence of specific information required to code using T codes, X44 is frequently 
used to code deaths due to ‘overdose’ which is often reported as such on the death 
certificates without any additional details. 
ICD 10 currently being used to report back to the EMCDDA according to the Spanish 
national definition are: F11-F12, F14-F16, F19, X42, X44, X62, Y12. X64 and Y14 are 
not included due to temporal comparability; however it is possible to select them.  
 
Analysis of DRDs in Spain  
 
The number of DRDs in persons aged between 15-64 years reported according to 
Selection B, Selection D and the national definition used in Spain varies as depicted 
in figure 17 below.    
Selection B includes ICD codes F11, F12, F14-F16, X42, X62 and Y12. Since no T codes 
are available codes X41, X61, Y11 as well as X44, X64 and Y14 are excluded. The 
National definition includes all codes reported in selection B but also includes X44 
code. Selection D reports according to the EMCDDA protocol for selection D but does 
not have national coverage. In Spain non-residents are included in the DRDs 
statistics. 
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Figure 17: Trends in DRDS in persons aged 15-64 years according to different 
definitions6 
 
In the ICD codes reported in table 34 below the ICD codes which account for the 
highest amounts of death are X44, X64, X42 and X49. However except for X42 these 
codes are relatively non specific in nature and with no T codes available. Therefore it 
is difficult to know the percentage of DRDs according to the EMCDDA protocol that 
would be found within these codes.   
 
 
 
Table 34: Number of deaths and percentage of deaths in a number of ICD codes 
related to DRDs in 2013 
 
A review of the trends in the number of deaths according to the ICD-10 codes that 
would be selected for selection B if T codes were available shows that a rise in the 
number of deaths coded as X44 occurred from 2005 onwards with a corresponding 
decrease in X42 codes and F codes (figure 18). The number of deaths in the other ICD 
codes remained relatively stable over the years. In figure 19 the main ICD codes 
responsible for most drug related deaths were compared to trends in DRDs 
according to selection B. One can observe a fall in the number of deaths according to 
selection B which follows a similar fall in the number of deaths in codes X42 and F 
codes. This occurred around the time of the ICD-10 updates related to DRDs and the 
shift of coding from X42 and F codes to X44 resulted in less deaths being reported to 
EMCDDA according to selection B.      
 
ICD-10 code
number of deaths % of deaths in 
these 
categories
Y14 7 0.86
Y12 0 0.00
Y11 2 0.25
X64 183 22.48
X62 4 0.49
X61 29 3.56
X44 289 35.50
X42 87 10.69
X41 30 3.69
F11,F12, F14-
F16,F19
22 2.70
Y19 7 0.86
X69 40 4.91
X49 114 14.00
Total 814 100.00
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Figure 18: Trends in DRDs according to ICD 10 code in the 15-64 age group5  
 
 
 
 
 
Figure 19: Trends in DRDs in 15-64 year olds according to the main ICD-10 codes and 
selection B5 
 
Analysis of unspecified ICD codes as a percentage of total deaths in the age groups 
15-64 revealed quite a high percentage in the R99 code and to a lesser extent in the 
X49 code in the younger age groups.   
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Table 35: % of deaths in specific ICD-10 codes out of all deaths in 2013 in Spain5  
 
 
 
Discussion and conclusion 
 
According to the national definition of Spain which includes reporting of DRDs due to 
X44 code (but not X64/Y14) the drug-induced mortality rate among adults (aged 15–
64) is 13 deaths per million in 2013, lower than the latest estimated European 
average of 19.2 deaths per million.  
Both the ICD-10 updates as well as the EMCDDA protocol for selection B can only be 
fully implemented in countries who’s GMR has information from toxicology reports 
regarding drug related deaths which are then translated into T codes.  
 
As described above reporting of DRDs according to selection B especially in recent 
years in Spain, resulted in a gross under-estimation of DRDs. This is a result of an 
increase in the use of X44 coding in 2004 and a fall in deaths due to X42 and F codes 
in 2004 and 2005 respectively. In countries that do not have T codes, deaths due to 
X44 code are not reported according to selection B. 
 
 
5.9 United Kingdom 
 
Situation analysis regarding ICD-10 coding vis a vis DRDs in the United Kingdom 
In collaboration with the United Kingdom National Focal Point: Martin White and Rosie 
Amery from Office for National Statistics 
 
Background 
 
The United Kingdom provides data on drug related deaths to the EMCDDA according 
to selection B. This is provided by three General Mortality Registers (England/Wales, 
Scotland and Northern Ireland). There is also one Special Mortality Register. 
However the United Kingdom does not report according to selection D.  
Though the United Kingdom report according to the EMCDDA definition of selection 
B, however at a National level two other definitions exist. ‘The Drug Misuse 
definition, developed for the United Kingdom’s former Drug Strategy, measures 
cases of death where the underlying cause is drug abuse, drug dependence or 
poisoning where any substances scheduled under the Misuse of Drugs Act 1971 are 
involved. The third definition, used by the Office for National Statistics, is much 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
Y19 0.00 0.00 0.12 0.00 0.00 0.00 0.06 0.00 0.01 0.01
X69 0.00 0.16 0.12 0.07 0.04 0.08 0.13 0.04 0.08 0.05
X49 0.26 0.33 0.94 1.01 0.75 0.77 0.23 0.10 0.10 0.01
R99 CODE 2.62 2.31 1.41 2.74 3.64 2.56 2.45 1.93 1.40 1.33
R98 CODE 0.26 0.33 0.59 0.36 0.50 0.54 0.41 0.36 0.13 0.14
R96.0/R96.1 0.26 0.82 0.70 0.72 0.50 0.34 0.23 0.17 0.12 0.09
I46 0.26 0.00 0.12 0.14 0.21 0.18 0.16 0.12 0.10 0.05
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wider than the other definitions and also includes death as a result of legal 
prescription and over-the-counter drugs’. 
 
Estimation of the number of Drug related deaths 
 
Deaths are not registered in England & Wales until investigations are complete, so 
the only certificate of cause of death that is issued is the final one. However if there 
is to be an inquest, an Interim Certificate of the Fact of Death can be issued to allow 
burial, however the death will only be registered once the inquest is concluded.  As 
England and Wales experience lengthy delays in the registration of these deaths, 
prior to 2015 deaths for England and Wales were reported according to year of 
registration. However in 2015 the UK made several changes in the reporting of 
Selection B which included that reporting for England & Wales changed to report by 
the year deaths occurred rather than the year of registration.  This is to give internal 
consistency with figures from Scotland which does not experience these delays. 
However, this means that the latest available reporting year will be two to three 
years behind, when it can be assumed that the large majority of deaths in England & 
Wales would have been registered.   
 
Multiple codes are recorded by ONS (England and Wales), however historically the T 
code was identified only if it is listed as the secondary cause of death. Names of 
substances are also recorded as these are used for the ‘drug misuse’ definition.   
 
Use of X44 and other ICD-10 codes in reporting drug related deaths 
 
Although the GMR is considered to be accurate, prior to current updates recently 
implemented, it was believed that figures reported to the EMCDDA were 
underestimated, particularly for England, due to a combination of the full protocol of 
selection B not being applied and historical coding practices around poly drug 
deaths. In England and Wales, there are a large number of X44/X64/Y14 cases 
historically, many of which are poly drug deaths. Also, figures for England and Wales 
previously only referred to the secondary cause of death to identify a T code.  In poly 
drug cases the secondary cause would be T50.9.  However, if all causes of death 
were looked at more closely, T40 codes could often be identified. Scotland has very 
few cases under X44/X64/Y14 even under the broader (‘ONS’) definition.  Therefore 
little change would be expected as a result of implementing the ICD-10 updates. 
Deaths with an underlying cause of death of X44, X64 and Y14 alongside relevant T-
codes have been incorporated into UK figures. Due to historical coding practice in 
England & Wales, this has substantially increased the number of deaths counted 
under this definition currently and historically. Figures for Scotland have also been 
revised, although there are very few cases under this definition, while deaths for 
Northern Ireland with these codes have been reported previously. Responsibility for 
calculation of England and Wales figures has moved from ONS to be calculated in-
house by the UK Focal Point, via Public Health England and Public Health Wales.  This 
has led to the exclusion of non-residents of England and Wales for reporting for 
those countries. 
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ONS have recently implemented a priority list so there will be fewer cases under 
these codes in future.  
 
Analysis of DRDs in the United Kingdom  
 
The number of drug related deaths according to selection B (figure 20 below) has 
been updated and figures are now fully compliant with the ICD-10 updates (of 
2002/2003 to be implemented in 2006) related to drug related deaths.  
 
 
 
Figure 20: Trends in the number of drug related deaths in the United Kingdom 
according to selection B  
 
Short term trends in drug related deaths according to selection B in England and 
Wales 
 
It was only possible to look at very short term trends in drug related deaths by ICD-
10 codes (figure 21). Most deaths are accounted for by ICD-10 codes X42/X62/Y12 
which are showing a short term rising trend. F and X41/X61/Y11 account for few 
deaths and show a short term stable trend. There is a decline each year in deaths 
due to X44/X64/Y14. This is because the Office for National Statistics implemented 
the coding change for deaths registered from the start of 2014, and many deaths 
from 2013 (and some from earlier years) will have been registered after that and so 
will be coded to e.g. X42 under the new priority list, rather than X44. 
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Figure 21: Short term trends in DRDs in England and Wales according to selection B 
 
Use of X44 code in England and Wales 
 
The use of X44/X64/Y14 in combination with other T codes except for T50.9 is very 
low or practically nil. On the other hand also as described previously X44/X64/Y14 in 
combination with T50.9 is very often used (Table 36) and often refers to poly-drug 
cases. An analysis undertaken by the UK focal point showed that a high percentage 
of the cases fit the criteria for reporting to the EMCDDA according to selection B 
(Table 37). No assessment has been made of the remaining cases to determine what 
other T codes are present. 
 
 
 
Table 36: Deaths due to X44/X64/Y14 in combination with T50.9 
 
 
 
Table 37: Percentage of deaths due to X44/X64/Y14 in combination with T50.9 which 
fit the EMCDDA criteria for selection B 
 
Unspecified deaths in the United Kingdom 
 
An analysis of the percentage of deaths within the unspecified drug related death 
codes X49/X69/Y19 as well as unspecified general codes R96,R98 and R99 resulted in 
a very low percentage of deaths within these ICD-10 codes (Table 38).  This indicates 
that few if any drug related deaths are lost to these non-specific codes which have 
ICD-10 code plus T code 2011 2012 2013
X44 T50.9 487 471 406
X64 T50.9 157 125 108
Y14 T50.9 97 113 77
Selection B plus T code 2011 2012 2013
X44 T50.9 62.4% (n= 304) 56.2% (n=262) 41.6% (n=169)
X64 T50.9 43.9 % (n=69) 36.8% (n=46) 24.1% (n=26)
Y14 T50.9 37.1% (n=36) 43.4% (n=49) 31.2% (n=24)
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been observed to be quite high in some countries especially when focusing on the 
15-64 age groups which account for most drug related deaths. 
 
 
 
Table 38: Percentage of deaths within non-specific ICD-10 codes in the United 
Kingdom in 20135 
 
 
The use of T43.8 (Other psychotropic drugs not elsewhere classified) and T43.9 
(Psychotropic drugs unspecified) within the ICD-10 X and Y codes reported to the 
EMCDDA (i.e: X40-X44, X60-X64, Y10-Y14) are very low and these have also been 
verified by the Focal Point for cases which fit the selection B criteria and reported 
accordingly. 
 
 
 
Table 39: Deaths coded using T43.8 and T43.9 in X and Y codes reported to EMCDDA 
 
Discussion and conclusion 
 
The drug-induced mortality rate among adults in the United Kingdom (aged 15–64) 
was 55.9 deaths per million in 2013, almost three time more than the most recent 
European average of 19.2 deaths per million. Following the recent revisions carried 
out to include deaths with an underlying cause of death of X44, X64 and Y14 
alongside relevant T-codes the United Kingdom is believed to capture a high 
percentage of drug related deaths with very little loss to non-specific codes. 
 
A bridge coding study was undertaken by the Office for National Statistics of the UK 
for mortality data of England and Wales of 2011, following the introduction of ICD 10 
version 2010 which replaced version 2001.2. The introduction of this new ICD-10 
version resulted in the number of deaths coded as mental and behavioural disorders 
due to drug use (ICD-10 codes F11–F16 and F18–F19) decreasing drastically (by 84%) 
with a corresponding increase in deaths due to ICD 10 codes X40-X44 (by 44%) (table 
40). 
 
Cause 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65& over
R96 0.96 0.74 0.50 0.50 0.29 0.17 0.06 0.02 0.02 0.01 0.00
R98 0.00 0.00 0.00 0.04 0.08 0.02 0.01 0.03 0.02 0.01 0.00
R99 1.39 1.47 1.70 1.51 1.81 1.40 1.18 0.76 0.66 0.46 0.08
X49 0.00 0.13 0.05 0.00 0.03 0.02 0.02 0.01 0.02 0.00 0.00
X69 0.00 0.00 0.05 0.00 0.11 0.02 0.01 0.00 0.01 0.00 0.00
Y19 0.00 0.07 0.05 0.00 0.11 0.02 0.02 0.01 0.01 0.00 0.00
T code 2011 2012 2013
T43.8 & T43.9 8 11 12
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Table 40: Number of deaths from drug related poisoning by underlying cause7  
 
In the United Kingdom all drug related deaths are certified by a coroner which 
results in an inquest. Therefore data on drug related deaths is very accurate, 
however there are often long delays resulting from the inquest which results in long 
delays in the release of drug related death data by year of death.    
 
 
6. Conclusion and Recommendations  
 
A detailed review of coding practices involving drug related deaths was undertaken 
in nine countries and a number of conclusions and recommendations are detailed 
below.  
 
6.1 Reporting according to selection B and Selection D or other national definition 
 
The reporting of drug related deaths according to selection B and selection D, often 
use different sources of information. In some countries the register which reports 
according to selection D was not developed to collect nationwide data on drug 
related deaths but rather to study poly drug use and the association of substances 
leading to death. 
In this case though not covering the whole population it can provide detailed 
information on the drugs involved in the drug related deaths.  
 
Recommendations 
 
• Countries are encouraged to report according to both sources as this is useful 
especially in monitoring trends; 
• Also in countries where it is known that gross underestimation of numbers of 
drug related deaths are being reported from the main source may be able to 
Number of deaths from drug-related poisoning: by sex and underlying cause, 2007-111,2
England and Wales3
2007 2008 2009 2010 2011
Males 662 705 586 504 86
Females 119 139 101 96 17
Males 725 861 983 899 1,107
Females 239 327 305 369 445
Males 520 500 524 482 576
Females 368 385 374 391 418
Males 7 9 5 5 3
Females 0 2 0 1 0
2 Figures are for deaths registered in each calendar year.
3 Figures for England and Wales include deaths of non-residents.
Source: Office for National Statistics, United Kigdom
Intentional self-poisoning by drugs, medicaments and biological 
substances (X60-X64), and poisoning by drugs, medicaments 
and biological substances, undetermined intent (Y10–Y14)
Assault by drugs, medicaments and biological substances 
(X85)
Deaths
1 Underlying cause of death was defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes given in 
the table.
Accidental poisoning by drugs, medicaments and biological 
substances (X40–X44)
Mental and behavioural disorders due to drug use (excluding 
alcohol and tobacco) (F11–F16, F18–F19)
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use the other source of data to make better estimates of number of drug 
related deaths. 
• Where possible linkage between the two sources, would help improve 
accuracy and completeness of both registers.     
• Detailed analysis of the main drugs and trends in drug type should be made 
by countries even if this is not possible at national level. 
 
6.2 Implementation of ICD-10 updates 
 
As discussed in the country reports above the implementation of ICD-10 updates has 
not been uniform across countries and there are various reasons for this which 
include:   
 
• The level of availability of information on drug related deaths detailed on the 
death certificate. The use of T codes and implementation of ICD-10 updates 
requires the availability of information on the specific drugs causing the death to 
be written on the death certificate. 
• In other cases information on the drugs causing the death may be available, 
however these may not be coded using T codes. 
• Sometimes although countries do include T code, due to the large number of 
cases with non specific information on the drugs causing the death, a large 
number of cases may have non-specific T codes such as T50.9 which would not 
be included in the EMCDDA Selection B definition.  
• Other countries may take some time to implement ICD-10 updates and do not 
implement them according to WHO recommendation timeframes. 
 
Also the effect of implementation of the ICD-10 updates on reporting of deaths 
according to selection B had different impacts.  
In some countries which have fully implemented the ICD-10 updates saw a shift in 
coding of drug related deaths from F codes to X and Y codes and also a shift to 
coding of more X44/X64/Y14. However this had no overall impact on the number of 
drug related deaths reported. 
 
On the other hand in countries who only partially implemented the ICD-10 updates 
due to e.g. lack of T codes saw a shift in coding from F and X42 to X44, but since 
X44/X64/Y14 should not be reported in selection B without T codes, this resulted in a 
corresponding decrease in the number of drug related deaths according to selection 
B. This was particularly seen in Spain which now use the national definition which in 
this case includes X44/X64/Y14.       
 
 
Recommendations 
 
• Countries need to make an effort to code all drugs using T codes even if in a 
number of cases not all drugs may be specified.  
• Updates should be implemented according to WHO recommended timeframes. 
Countries should be informed about an update related to drug related deaths 
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well in advance. This could be done through WHO invited experts at the EMCDDA 
annual meeting on drug related deaths. 
• Countries are encouraged to carry out bridge coding exercise when ICD updates 
are implemented to assess the impact of the update. 
 
 
6.3 Non specific ICD 10 codes 
 
An analysis was undertaken were possible to review deaths coded as X44/X64/Y14 
and corresponding T50.9. As described previously in this report cases placed under 
this code may be those in which not enough information is available to be able to 
identify and therefore code the drug specifically or the type of drug was specified, 
but is classified among the "rest" category in T50.9 as no specific code exist. The 
extent of use of T50.9 varied between countries as was the extent of use of other 
unspecified drug related death codes such as X49/X69/Y19. Also the extent to which 
cases to be reported under selection B could be possibly found under these non 
specific codes varies. However in countries were the majority of drug related death 
are coded with these non specific codes would definitely have a high degree of 
under-reporting to the EMCDDA when reporting according to selection B.  
 
Other non-specific general codes in the younger age groups were also analysed but 
little conclusion can be drawn at this point about what the figures mean.   
 
In some countries specific information about a drug may arrive late, possibly 2-3 
years after the death had occurred. These are sometimes coded non-specifically 
initially but updated when more information becomes available. 
 
 
Recommendations 
 
• In countries where this is possible analysis of cases coded under T50.9 should be 
undertaken, similar to that done by England. 
• Further discussion by EMCDDA with WHO regarding deaths due to drugs with no 
specific T code should also be considered. 
• Countries should make an effort to obtain more information about drug related 
cases with an unspecified T code e.g. using T50.9   and linkage with other 
registers e.g. a drug register should be considered if permitted.  
• EMCDDA to consider asking for an update of drug related death data 2-3 years 
after the initial request to take into consideration possible updates. 
  
  
6.4 Conclusions 
 
There are wide discrepancies in the reporting of drug related deaths by countries 
and often it is difficult to make any inferences form the reported data due to known 
certification and coding issues.  
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Countries who are aware of gross underestimation in the reporting of drug related 
deaths according to the EMCDDA definition could possibly develop a method of 
estimation to be able to produce a more realistic figure. Country examples of 
estimation exist. 
Further collaboration between the General Mortality Register and the Special 
Register could also be a way of improving the quality and comprehensiveness of the 
data.      
In countries which code all drugs involved in the death, multiple cause analysis can 
be undertaken to evaluate in more detail the trends in the drugs involved in drug 
related deaths. 
 Also in countries where this is possible it would be interesting to try to analyse 
further the deaths especially in the younger age groups which were given an 
unspecified code such as T50.9 and R99.   
 
Finally the EMCDDA selection B definition should be always kept under review, firstly 
due to the effect of ICD-10 updates and ICD-11, but also due to how countries are 
managing to report according to this definition.     
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8. Annexes 
 
Annex A 
 
13th June 2016 
 
Dear National Expert, 
 
 
Re: The collection and analysis of data on DRDs in order to contribute to the 
EMCDDA review of the drug-induced deaths data at codification level 
 
 
Background and rationale 
 
The collection of data regarding drug related deaths varies from country to country, 
with variations occurring at certification level and also at codification level. Previous 
work carried out by the EMCDDA (European Monitoring Centre for Drugs and Drug 
Addiction) and presented at the 2015 September 21-22 annual expert meeting1 has 
shown that coding of drug related deaths varies between countries, and the 
adoption of the ICD-updates in DRDs of 2002/03 (to be implemented in 2006 and as 
described in the EMCDDA DRD protocol2) has not been uniform across countries1. 
The aim of this project is, that through the collection of detailed data on drug related 
deaths from a number of countries, to further analyse this data in terms of 
codification practices.  
 
The aim of this part of the project is to: 
 
d) Describe the disaggregated dataset of DRD cases, (according to what 
countries can provide) including all retrieval codes and information on 
causes of death. 
e)  Analyse the DRD data from selected countries in order to describe in 
particular the cases captured under X44, X64 and Y14;  
 
 
I have been entrusted by EMCDDA to perform this work and in order to be able to 
carry out the detailed analysis we kindly ask each national expert on DRDs in the 
selected countries to provide the following information on the cases as per protocol 
below for the last 3 most recent years, from the GMR (and also from the SR, should 
codes be available from these as well). We expect case-based data on the variables 
described below according to availability of information.   
 
The dataset you will be sending will be solely under my responsibility (and no one 
other than EMCDDA person in charge will have access to your data) however it is 
very important, that no identifiable data should be included in the dataset that you 
provide me or EMCDDA for this project.  
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Data requested 
 
Data is being requested for three consecutive years of data (preferably latest 
available) for all deaths requested. Note that the extracted and reported cases 
should include cases with the following ICD-10 codes as underlying cause of death: 
 
F11 (.0-.9) to F19 (.0-.9), (excluding F17), X41, X42, X44, X49, X61, X62, X64, X69, Y11, 
Y12, Y14, Y19, R96.0, R96.1, R98, R99 if possible. 
 
 
 For each case the following variables are being requested according to what is 
available: 
 
 
Variable 
Number 
Variable Description/coding Example 
1 Reference number A unique number for 
this dataset given to a 
case by the country 
(should not be 
identity number ) 
1, 2, etc 
2 Sex 1=Male, 2=female, 
3=Unknown  
 
3 If included or not 
in yearly EMCDDA 
request  
1= Yes, 0= No,   
4 Year of death  2014, 2013, 2012 
5 Age at death If possible single years 
of age, otherwise as 
per EMCDDA 
groupings  
 
6 Causes of death 
text including all 
mentioned drugs 
and alcohol  
Text as given on the 
cause of death section 
of the death 
certificate (if possible 
in English)  
e.g. part I: overdose 
by heroin and 
cocaine; 
part II: high alcohol 
levels 
7 List of all 
substances 
identified 
All substances 
reported (from in the 
toxicology analysis, or 
from the text of the 
death certificate)  
(e.g. alcohol, 
prescription drugs, 
illicit psychoactive 
substances…) 
Heroin, cocaine, 
alcohol 
8 Code of the F11 (0.0-0.9) to F19 e.g. X42.0 T40.1, 
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underlying cause 
of death and if 
available T codes 
considered as 
directly related to 
the cause of death. 
(0.0-0.9) (excluding 
F17), X41, X42, X44, 
X49, X61, X62, X64, 
X69, Y11, Y12, Y14, 
Y19, R96.0, R96.1, 
R98, R99;  
T40.5 
9 All other ICD codes 
especially T codes. 
This should include 
those codes also 
not considered as 
directly related to 
cause of death 
 e.g. T51.9 
10 Intentionality Especially if using F 
codes e.g. if 
accidental, suicide, 
homicide or unknown 
 
11 If autopsy and 
toxicology was 
done. 
1=Yes, 2=No 3 
unknown 
 
 
 
Table 1: Variables to be reported for each case according to availability 
 
If it not possible to report each case with all the above mentioned variables, kindly 
report case based data with the variables which are available for your country. 
 
Also if it is not possible to provide case-based data with the above mentioned ICD-10 
codes, we kindly ask you to provide case based data according to EMCDDA selection 
B (as per DRD protocol available from 
http://www.emcdda.europa.eu/system/files/publications/615/DRD_Standard_Proto
col_version_3.2_216365.pdf pgs 32 and 68)  together with the above mentioned 
variables in table 1 as is available in your country.    
 
Analysis to be performed 
 
Depending of the availability of detailed disaggregated (case based) data sent to me 
for your country the following analysis will be carried out: 
 
1) Describe what cases have been being captured under the ICD codes of X44, X64 
and Y14. 
 
In order to carry out this analysis the relevant T codes used in combination with X44, 
X64 and Y14 would ideally be supplied by the countries to be able to analyse in detail 
what these codes are being used for.  
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Describe the full disaggregated dataset of DRD cases (for 3 consecutive years, 
according to what your country can provide) including all retrieval codes and 
information, for the ‘detailed dataset’.  
 
This will be done for those countries which are able to supply the dataset and if 
possible textual causes of death. A detailed analysis can be done of the different 
codes, where DRDs may be present but not routinely sent to EMCDDA due to lack of 
detailed information about the case and what % they would contribute too. 
 
 
 
Following the analysis carried out above, a summary report per country supplying us 
with the detailed information will be done and discussed with the particular national 
expert and EMCDDA. This will include an overview on the data existing in this area 
and other analysis according to what is made available by the particular country. 
 
The country specific analysis will contribute to a larger overall analysis of all 
countries studied and which will report on common and other particular issues 
identified, comparability issues raised, as well as recommendations and ways 
forward and will be submitted to EMCDDA. 
  
All national experts and national focal points who participate will be acknowledged 
in the report produced. 
 
I would like to thank you in advance for contributing to this project and hope to 
receive your data by latest 4th July 2016. Please feel free to contact me in case 
difficulty or if you have any queries. 
 
 
Kind regards 
 
Kathleen 
 
 
Dr Kathleen England 
Public Health Medicine Specialist 
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Annex B 
 
ICD codes requested in persons aged 15-64 years 
   
        
ICD-10 code   
 
ICD-10 code plus T code 
 
ICD-10 
code 
plus T 
code 
F11.0 F14.7 
 
X41 T42.3 
 
X42 T40.0 
F11.1 F14.8 
 
X41 T42.4 
 
X42 T40.1 
F11.2 F14.9 
 
X41 T42.5 
 
X42 T40.2 
F11.3 F15.0 
 
X41 T42.6 
 
X42 T40.3 
F11.4 F15.1 
 
X41 T42.7 
 
X42 T40.4 
F11.5 F15.2 
 
X41 T43.6 
 
X42 T40.5 
F11.6 F15.3 
 
X61 T42.3 
 
X42 T40.6 
F11.7 F15.4 
 
X61 T42.4 
 
X42 T40.7 
F11.8 F15.5 
 
X61 T42.5 
 
X42 T40.8 
F11.9 F15.6 
 
X61 T42.6 
 
X42 T40.9 
F12.0 F15.7 
 
X61 T42.7 
 
X62 T40.0 
F12.1 F15.8 
 
X61 T43.6 
 
X62 T40.1 
F12.2 F15.9 
 
Y11 T42.3 
 
X62 T40.2 
F12.3 F16.0 
 
Y11 T42.4 
 
X62 T40.3 
F12.4 F16.1 
 
Y11 T42.5 
 
X62 T40.4 
F12.5 F16.2 
 
Y11 T42.6 
 
X62 T40.5 
F12.6 F16.3 
 
Y11 T42.7 
 
X62 T40.6 
F12.7 F16.4 
 
Y11 T43.6 
 
X62 T40.7 
F12.8 F16.5 
    
X62 T40.8 
F12.9 F16.6 
    
X62 T40.9 
F13.0 F16.7 
    
Y12 T40.1 
F13.1 F16.8 
    
Y12 T40.2 
F13.2 F16.9 
    
Y12 T40.3 
F13.3 F18.0 
    
Y12 T40.4 
F13.4 F18.1 
    
Y12 T40.5 
F13.5 F18.2 
    
Y12 T40.6 
F13.6 F18.3 
    
Y12 T40.7 
F13.7 F18.4 
    
Y12 T40.8 
F13.8 F18.5 
    
Y12 T40.9 
F13.9 F18.6 
      F13.10 F18.7 
      F13.11 F18.8 
      F13.12 F18.9 
      F13.13 F19.0 
      F13.14 F19.1 
      F13.15 F19.2 
      F13.16 F19.3 
      F13.17 F19.4 
      F13.18 F19.5 
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F13.19 F19.6 
      F14.0 F19.7 
      F14.1 F19.8 
      F14.2 F19.9 
      F14.3   
      F14.4   
      F14.5   
      F14.6   
      
        ICD-10 code plus T code 
 
ICD-10 code plus T code 
   X44 T42.3 
 
X4* T43.8 
   X44 T42.4 
 
X4* T43.9 
   X44 T42.5 
 
    
   X44 T42.6 
 
X6* T43.8 
   X44 T42.7 
 
X6* T43.9 
   X44 T43.6 
 
    
   X44 T40.0 
 
Y1* T43.8 
   X44 T40.1 
 
Y1* T43.9 
   X44 T40.2 
 
X44 T50.9 
   X44 T40.3 
 
X49 T50.9 
   X44 T40.4 
 
X64 T50.9 
   X44 T40.5 
 
X69 T50.9 
   X44 T40.6 
 
Y14 T50.9 
   X44 T40.7 
 
Y19 T50.9 
   X44 T40.8 
 
    
   X44 T40.9 
 
R96.0   
   X64 T42.3 
 
R96.1   
   X64 T42.4 
 
R98   
   X64 T42.5 
 
R99   
   X64 T42.6 
      X64 T42.7 
      X64 T43.6 
      X64 T40.0 
      X64 T40.1 
      X64 T40.2 
      X64 T40.3 
      X64 T40.4 
      X64 T40.5 
      X64 T40.6 
      X64 T40.7 
      X64 T40.8 
      X64 T40.9 
      Y14 T42.3 
      Y14 T42.4 
      Y14 T42.5 
      
61 
 
Y14 T42.6 
      Y14 T42.7 
      Y14 T43.6 
      Y14 T40.0 
      Y14 T40.1 
      Y14 T40.2 
      Y14 T40.3 
      Y14 T40.4 
      Y14 T40.5 
      Y14 T40.6 
      Y14 T40.7 
      Y14 T40.8 
      Y14 T40.9 
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Annex C 
 
ANALYSIS OF 2012 CAUSES OF DEATH 
French National Focal Point: Anne-Claire Brisacier 
Table 1. Synthesis of underlying causes of death in French selection B in 2012 
Causes of death Certain overdoses 
Likely 
overdose
s 
Deaths 
of drug 
users 
not 
related 
to 
overdos
e  
Overdos
e out of 
context 
of 
addictio
n or use 
of drugs 
Tota
l 
Code ICD 10 underlying 
causes N % N % N % N % N 
F11 4 19,0 13 61,9 3 14,3 1 4,8 21 
F12 0 0,0 4 
100,
0 0 0,0 0 0,0 4 
F14 0 0,0 3 
100,
0 0 0,0 0 0,0 3 
F15 0 0,0 1 
100,
0 0 0,0 0 0,0 1 
F19 1 0,9 88 79,3 
1
6 14,4 6 5,4 111 
Total F 5 3,6 
10
9 77,9 
1
9 13,6 7 5,0 140 
X42 63 64,3 15 15,3 2 2,0 
1
8 18,4 98 
X62 8 34,8 10 43,5 0 0,0 5 21,7 23 
Y12 2 66,7 1 33,3 0 0,0 0 0,0 3 
Total French selection B 78 29,5 
13
5 51,1 
2
1 8,0 
3
0 11,4 264 
Source : Données CépiDc, INSERM, exploitation OFDT. 
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Figure 1 : Synthesis of underlying causes of death in French selection B in 2012
 
Source : Données CépiDc, INSERM, exploitation OFDT. 
 
Conclusion on 2012 data :  
 
In 2012, 264 deaths were identified by CépiDc via the French definition of the 
selection B. According to our analysis, 81 % of them can be considered as overdoses, 
in a more or less certain way (30 % of certain overdoses and 51 % of likely 
overdoses), whereas the remaining 19 % constitute false positive, representing 
deaths of drug users not related to an overdose (8 %) or deaths by opiates overdose 
out of drug (11 %). 
 
Concerning the methods of coding, the codes T are little associated to the codes X 
and Y. However, according to our study, to associate these codes would be possible 
only in a third of the deaths, this modification being limited by the lack of precision 
of substances mentioned in death certificates.  
In addition to these cases, deaths by overdose not identified as such because not 
coded by a code of the French selection B in underlying cause could be added: 76 
coded cases X41/X61/Y11 or X44/X64/Y14 (11 and 65 respectively) could be 
considered as overdoses (among which 30 have a code of the French selection B but 
not as underlying cause). Furthermore, 48 other cases involving a drug could be also 
considered overdoses but don’t appear as such because of the choice of another 
underlying cause, masking the information concerning the drug (myocardial 
infarction for 11 cases and alcohol consumption for 27 cases). 
  
30% 
51% 
8% 
11% 
19% 
2012 
Certain overdoses
Likely overdoses
Deaths of drug users not related to overdose
Overdoses out of  use of drugs
False positive 
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ANALYSIS OF 2013 CAUSES OF DEATH  
Tableau 2. Synthesis of underlying causes of death in French selection B in 2013 
Causes of death Certain overdoses Likely overdoses 
Deaths 
of drug 
users not 
related 
to 
overdose  
Overdose 
out of 
context 
of 
addiction 
or use of 
drugs 
Total 
Code ICD 10 underlying causes N % N % N % N % N 
F11 2 9,5 12 57,1 7 33,3 0 0,0 21 
F12 0 0,0 2 66,7 1 33,3 0 0,0 3 
F14 0 0,0 8 100,0 0 0,0 0 0,0 8 
F15 0 0,0 0 0,0 0 0,0 0 0,0 0 
F19 4 3,3 89 73,6 24 19,8 4 3,3 121 
Total F 6 3,9 111 72,5 32 20,9 4 2,6 153 
X42 88 53,0 21 12,7 1 0,6 56 33,7 166 
X62 16 55,2 12 41,4 0 0,0 1 3,4 29 
Y12 1 100,0 0 0,0 0 0,0 0 0,0 1 
Total French sélection B 111 31,8 144 41,3 33 9,5 61 17,5 349 
Source : Données CépiDc, INSERM 
 
 
Figure 2: Synthesis of underlying causes of death in French selection B in 2013
 
Source : Données CépiDc, INSERM 
 
 
32% 
41% 
10% 
17% 
27% 
2013 
Certain overdoses
Likely overdoses
Deaths of drug users not related to
overdose
False positive 
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Conclusion on 2013 data :  
 
In 2013, 349 deaths were identified by CépiDc via the French definition of the 
selection B. According to our analysis, 73 % of them can be considered as overdoses, 
in a more or less certain way (32 % of certain overdoses and 41 % of likely 
overdoses), whereas the remaining 27 % constitute false positive, representing 
either deaths of drug users not relates to an overdose (10 %) or deaths by opiates 
overdose out of drug (17 %). 
Compared with 2012, there is an increase of the false positive (from 19 to 27 % is an 
increase of 8 points), which contributes to produce lower-quality data which can 
explain partially the increase of the number of deaths by overdose between 2012 
and 2013. Indeed, the number of deaths by overdose increased by 85 cases (from 
264 to 349 deaths) between these two years. The false positives’ increase of 8 points 
- essentially overdoses of morphine or other opiates - correspond to an increase of 
30 deaths (8 % of 349 deaths). There are thus 55 additional deaths not attributable 
to the false positive in the increase of the 2012 deaths. It would thus seem that the 
"real" number of deaths by overdose increased itself. 
In addition to these cases could be added deaths by overdose not identified as such 
because not coded by a code of the French version of the selection B in initial cause: 
43 coded cases X41 X41/X61/Y11 X61 or X44 X44/X64/Y14 X64 (11 and 32 
respectively) could be considered as overdoses, among which 39 possessing a code 
of the selection B French.       
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